is an essential ion in all organisms, where it plays a crucial role in processes ranging from the formation and maintenance of the skeleton to the temporal and spatial regulation of neuronal function. The Ca 2ϩ balance is maintained by the concerted action of three organ systems, including the gastrointestinal tract, bone, and kidney. An adult ingests on average 1 g Ca 2ϩ daily from which 0.35 g is absorbed in the small intestine by a mechanism that is controlled primarily by the calciotropic hormones. To maintain the Ca 2ϩ balance, the kidney must excrete the same amount of Ca 2ϩ that the small intestine absorbs. This is accomplished by a combination of filtration of Ca 2ϩ across the glomeruli and subsequent reabsorption of the filtered Ca 2ϩ along the renal tubules. Bone turnover is a continuous process involving both resorption of existing bone and deposition of new bone. The above-mentioned Ca 2ϩ fluxes are stimulated by the synergistic actions of active vitamin D (1,25-dihydroxyvitamin D 3 ) and parathyroid hormone. Until recently, the mechanism by which Ca 2ϩ enter the absorptive epithelia was unknown. A major breakthrough in completing the molecular details of these pathways was the identification of the epithelial Ca 2ϩ channel family consisting of two members: TRPV5 and TRPV6. Functional analysis indicated that these Ca 2ϩ channels constitute the rate-limiting step in Ca 2ϩ -transporting epithelia. They form the prime target for hormonal control of the active Ca 2ϩ flux from the intestinal lumen or urine space to the blood compartment. This review describes the characteristics of epithelial Ca 2ϩ transport in general and highlights in particular the distinctive features and the physiological relevance of the new epithelial Ca 2ϩ channels accumulating in a comprehensive model for epithelial Ca 2ϩ absorption.
I. INTRODUCTION
The maintenance of the extracellular Ca 2ϩ concentration is of utmost importance for many vital functions of the body. In face of large variations in Ca 2ϩ in-and output, the organism is equipped with a set of regulatory systems to keep the plasma Ca 2ϩ levels around a value of 2.5 mM. To this end, the Ca 2ϩ fluxes between the extracellular compartment and several organ systems are tightly controlled.
Ca 2ϩ absorption occurs in epithelia, including kidney, intestine, placenta, mammary glands, and gills. In mammals, the small intestine and kidney constitute the influx pathways into the extracellular Ca 2ϩ pool, while fish have an additional specialized organ for Ca 2ϩ uptake, the gills (426) . In addition, during reproductive events, Ca 2ϩ transport in the placenta and mammary glands can seriously influence the Ca 2ϩ balance (29, 345) . For instance, during lactation, plasma Ca 2ϩ levels can significantly drop due to Ca 2ϩ excretion into the milk. Furthermore, during pregnancy Ca 2ϩ transport from the mother to the fetus takes place across the placenta and challenges the plasma Ca 2ϩ concentration. The Ca 2ϩ demand is great in children during skeletal growth and decreases gradually with advancing age. Finally, factors as pH, extracellular Ca 2ϩ concentration, and various hormones have been shown to influence the Ca 2ϩ movement across epithelia (37, 129, 175) .
In general, Ca 2ϩ transport is mediated by a complex array of transport processes that are regulated by hormonal, developmental, and physiological factors. The distinct processes by which Ca 2ϩ can be absorbed across epithelial tissues include paracellular and transcellular pathways. The paracellular pathway allows the direct exchange of Ca 2ϩ between two compartments, while the transcellular route involves transport across at least two plasma membrane barriers (Fig. 1) . The vitamin D metabolite 1,25-dihydroxyvitamin D 3 [1, 2 D 3 ] and parathyroid hormone (PTH), among others, are prominent hormones controlling the Ca 2ϩ balance. Numerous methods have been utilized to study the process of Ca 2ϩ absorption. Traditionally, metabolic balance, micropuncture, and radioactive tracer techniques were employed to estimate epithelial Ca 2ϩ fluxes in humans and animal models. More recently, freshly isolated epithelia and established cell models were used to measure Ca 2ϩ transport by radioisotopes of Ca 2ϩ and fluorescent indicators. Finally, molecular biological tools were applied to identify and characterize the individual transport proteins and to develop new animal and cell models to further delineate the process of Ca 2ϩ transport. As a consequence, current research is beginning to define the molecular mechanisms, the regulation, and coordination of the epithelial Ca 2ϩ transport mechanisms (35, 125) . Here, we review our present understanding of these processes in detail and discuss potential implications for further research.
II. PARACELLULAR TRANSPORT
A fundamental function of epithelia is to separate different compartments within the organism and to regulate the exchange of substances between them (151, 425) . Epithelia consist of a continuous layer of individual cells, and the intercellular spaces between the epithelial cells are very narrow, but nonetheless allow the diffusion of small molecules and ions (152) . This route is called the paracellular pathway, which must be regulated for the epithelium to remain selectively permeable (Fig. 1 ). Depending on the functional requirements of an epithelium, there may be small or large amounts of solutes flowing passively through this path. The tight junction constitutes the barrier to the passage of ions and molecules through the paracellular pathway (5) . In general, the importance of this route has not been as thoroughly investigated as the role of the transepithelial pathway. However, recent studies identifying the molecular components of the paracellular transport route as causally related to particular inherited diseases, including familial hypomagnesemia (353) , hypertension (429) , and autosomal recessive deafness (428) , confirm the importance of paracellular transport.
A. Tight Junction
The tight junction is a specialized membrane domain at the most apical region of polarized epithelial cells that not only creates a primary barrier to prevent paracellular transport of solutes, but also restricts the lateral diffusion of membrane lipids and proteins to maintain the cellular polarity. Tight junctions are intercellular structures in which the plasma membranes of adjacent epithelial cells come into very close contact. These structures consist as linear arrays of integral membrane proteins, which include occludin, claudins, and several immunoglobulin superfamily members, such as the junctional adhesion molecule (98, 152, 248) . The claudin family consists of at least 20 related integral membrane proteins with four transmembrane (TM) domains and functions as major structural components of the tight junctional complex, while occludin is an accessory protein involved in the tight junction formation of which three isoforms have been described (262, 378, 384) .
It has been hypothesized that tight junctions behave similar to conventional ion channels, while others have suggested a function as water-filled channels with no ion selectivity (5, 384, 434) . Recently, it was shown by applying new technology that the tight junction complex manifests biophysical properties of ion channels including ion and size selectivity, concentration-dependent ion permeability, competition between permeable molecules, anomalous mole-fraction behavior, and sensitivity to pH (378) . This latter study suggests that discrete ion channels are being inserted in the tight junction to facilitate paracellular ion transport. This is further supported by the disease mutations documented in claudins (434) . Mutations in claudin-16, which are associated with a renal Mg 2ϩ wasting syndrome, implicate this particular claudin in paracellular resorption of Mg 2ϩ and Ca 2ϩ , but not monovalent ions (353) . Mutations in claudin-14 cause nonsyndromic recessive deafness, and this tight junction protein is essential to maintain the electrochemical gradient between the endolymph and its surrounding tissues (428) .
B. Regulation
Movement of ions through the tight junctions is a passive process, which largely depends on the concentration gradient of the permeable ions and the electrical gradient across the epithelium. Hormones and factors affecting the electrochemical gradient across the epithelium, therefore, indirectly influence the passive fluxes through the tight junctions. The tight junction permeability itself is dynamically regulated under various physiological conditions (152, 299) . Tight junctions undergo modulation by growth factors, cytokines, bacterial toxins, hormones, and other factors (30, 134, 153, 419) . Some studies suggest that phosphorylation of tight junction proteins plays a role in tight junction assembly and function. Modulation of protein kinase C (PKC) disrupts the cellcell junctions of epithelial cells, whose action is supposedly mediated by mitogen-activated protein kinase (419) . 2ϩ transport by increasing the expression levels of the luminal Ca 2ϩ channels, calbindins, and the extrusion systems. Active and transcellular Ca 2ϩ transport is carried out as a three-step process. Following entry of Ca 2ϩ through the (hetero)tetrameric epithelial Ca 2ϩ channels, TRPV5 and TRPV6, Ca 2ϩ bound to calbindin diffuses to the basolateral membrane. At the basolateral membrane, Ca 2ϩ is extruded via a ATP-dependent Ca 2ϩ -ATPase (PMCA1b) and a Na ϩ /Ca 2ϩ exchanger (NCX1). In this way, there is net Ca 2ϩ absorption from the luminal space to the extracellular compartment.
Recently, the serine-threonine kinase WNK4 has been identified as part of the junctional complex, and mutations in this protein cause pseudoaldosteronism type II, a Mendelian trait featuring hypertension (429) . Furthermore, a serine-threonine-dependent phosphorylation of tight junction proteins has been shown to enhance the paracellular permeability in rabbit nasal epithelium (294) . These studies underline the essential role of serine-threonine kinase in the regulation of the paracellular route, but the precise mechanism remains to be established.
III. TRANSCELLULAR TRANSPORT
Transcellular Ca 2ϩ transport is a multistep process, comprised of the transfer of luminal Ca 2ϩ into the enterocyte or renal epithelial cell, the translocation of Ca 2ϩ from point of entry to the basolateral membrane, and finally active extrusion from the cell into the circulatory system ( Fig. 1) .
A. Calcium Entry
Ca 2ϩ is postulated to enter the epithelial cell via Ca 2ϩ -selective channels at the luminal membrane under the influence of a steep, inwardly directed electrochemical gradient. The molecular nature of the apical entry mechanism has remained obscure for a long time. In the past, the mechanism responsible for the luminal entry of Ca 2ϩ has been extensively characterized in renal and intestinal cells, but these studies have not led to the definite identification of this Ca 2ϩ transporter. A variety of studies implicated Ca 2ϩ channels in mediating Ca 2ϩ entry in absorptive epithelia (206, 228, 443) . From these studies it is likely that several distinct Ca 2ϩ channels, which resemble the classified voltage-dependent Ca 2ϩ channels in part, are present in cells of the distal part of the nephron (443) . Previous studies indicated the presence of the pore-forming subunit ␣ 1A or ␣1 of a Ca 2ϩ channel expressed in the Ca 2ϩ -transporting renal cells. In general, voltage-sensitive Ca 2ϩ channels are heteromeric, multisubunit proteins, as has been well demonstrated for the skeletal muscle (69) and brain (431) channels, and their properties are not only determined by the ␣1-subunit itself, but also depend on the presence of regulatory subunits. Of these, the ␤ 3 -subunit might be an interesting subunit, which can influence such fundamental channel properties as current amplitude (355) , kinetics (226, 355, 400) , voltage dependence (355) , and regulation by cyclic nucleotide-dependent protein kinases (216) . Stimulation of the Ca 2ϩ influx channel in the renal distal tubule by the calciotropic hormone PTH is thought to be mediated by both protein kinase A (PKA) and PKC (124, 170) . Comparable studies in rat duodenum pointed to acute effects of 1,25-(OH) 2 D 3 on Ca 2ϩ influx in isolated enterocytes (112-114, 144, 152) . This calciotropic hormone significantly increased 45 Ca 2ϩ uptake within 1-10 min in a dose-dependent manner (249) . The effects of 1,25-(OH) 2 D 3 were mimicked by the Ca 2ϩ channel agonist BAY K 8644 and completely abolished by nifedipine and verapamil. Incubation of duodenal cells with 1,25-(OH) 2 D 3 rapidly (1-5 min) increased cAMP levels. Forskolin caused a rapid increase in Ca 2ϩ uptake by enterocytes that was similar to the action of the hormone. Moreover, pretreatment of cells with the specific cAMP inhibitor R p -cAMPS suppressed the changes in 45 Ca 2ϩ influx induced by 1,25-(OH) 2 D 3 . These results suggested the involvement of a Ca 2ϩ channel activation through the cAMP/PKA-pathway by 1,25-(OH) 2 D 3 in mammalian intestinal cells (249) . However, the physiological significance of these postulated Ca 2ϩ channels with respect to Ca 2ϩ influx during Ca 2ϩ (re)absorption remains unclear, since most of the studies were performed in single cell systems rather than in polarized epithelia derived from kidney or duodenum epithelia. With the use of these nonpolarized cell preparations, it was not feasible to discriminate between apical versus lateral Ca 2ϩ influx. Until now, two polarized confluent epithelial cell systems representing active duodenal and renal Ca 2ϩ (re)absorption have been studied. First, Caco-2 cells were employed, which represent an intestinal cell line derived from a human colorectal carcinoma that spontaneously differentiates under standard culture conditions in a tissue that exhibits functional duodenal transport processes (144) . These cells become polarized columnar epithelial cells, form tight junctions and domes, and express several markers that are unique to differentiated small intestinal epithelium (e.g., high sucrase-isomaltase mRNA and protein levels) (72). Caco-2 cells exhibit saturable apical-to-basolateral Ca 2ϩ transport kinetics, net transport is positive in the apical-to-basolateral direction, and the rate of transport can be increased by pretreatment with 1,25-(OH) 2 D 3 (114, 143) . Vitamin Dinduced upregulation of Ca 2ϩ transport requires transcriptional events (114) and is modulated by changes in the vitamin D receptor (VDR) content of the cell (342) . Second, the use of primary cultures and immortalized cell lines originating from the renal distal tubular cells greatly facilitated our understanding of Ca 2ϩ influx in these cells and how PTH and 1,25-(OH) 2 D 3 regulate transepithelial Ca 2ϩ transport. Two groups, Bindels and co-workers (36 -39, 170, 172, 177, 320, 389 -391) and Gesek and Friedman and co-workers (12, 120, 124, 126 -128, 139, 138, 246, 427) , have used immunodissected cell lines from rabbit and mouse kidney, respectively, to investigate PTH-stimulated Ca 2ϩ transport. These studies verified that PTH increases transepithelial Ca 2ϩ transport and suggested that both PKA and PKC participate in this process (124, 170) . In addition, Bindels and co-workers demonstrated that the primary cultures of rabbit connecting tubule (CNT) and cortical collecting duct (CCD) cells exhibit many charac-teristics of the original epithelium, including 1,25-(OH) 2 D 3 -and vasopressin-stimulated Ca 2ϩ reabsorption (36 -39, 50, 170, 172, 177, 218) . The stimulatory effect of cAMP/PKA on apical Ca 2ϩ influx is in agreement with a report of Tan and Lau (377) , describing a 25-pS, cAMPsensitive apical Ca 2ϩ channel in rabbit kidney CNT cells, that is inhibited by dihydropyridine agonists and depolarization. However, luminal administration of a variety of Ca 2ϩ channel antagonists, including dihydropyridines, failed to affect Ca 2ϩ absorption in primary cultures of these CNT tubules, suggesting that Tan and Lau (377) did not study the apical entry Ca 2ϩ mechanism. Previous studies indicated that over a wide range of transepithelial Ca 2ϩ transport rates, the Ca 2ϩ influx at the apical membrane is correlated in a 1:1 fashion with the apical to basolateral 45 Ca 2ϩ flux (320) . The mechanism underlying this tight coupling could in principle be located at three distinct Ca 2ϩ transport positions, namely, influx, cytosolic diffusion, or efflux (175, 320) . Ca 2ϩ influx across the apical or luminal membrane could be the ratelimiting step for transcellular Ca 2ϩ transport. This would imply that the availability of cytosolic Ca 2ϩ for the basolateral Ca 2ϩ efflux pumps controls the rate of Ca 2ϩ efflux. This is in line with the finding that apical H ϩ directly inhibits the Ca 2ϩ influx pathway and consequently decreases the intracellular Ca 2ϩ concentration, which in turn limits the Ca 2ϩ extrusion (37) . In addition, extracellular H ϩ are known to inhibit voltage-gated Ca 2ϩ channels in excitable tissues by changing their conformations and modifying their gating properties.
To unravel the molecular identity of the apical Ca 2ϩ influx protein in Ca 2ϩ -transporting epithelia, several different experimental strategies have been employed. The classic approach of purification of the Ca 2ϩ transporter followed by amino acid sequencing of the isolated peptide has been hindered by the lack of a rich source of channel protein. In another strategy, a calbindin-D 28K affinity column has been applied to purify associated proteins potentially involved in transepithelial Ca 2ϩ (re)absorption (191) . Previous studies indicated that the intracellular Ca 2ϩ concentration is a critical determinant for Ca 2ϩ influx. In theory, the Ca 2ϩ buffer calbindin, which reaches submillimolar concentrations in these epithelial cells, might interact with this putative influx channel to buffer and bind Ca 2ϩ in a rapid way to facilitate an efficient Ca 2ϩ transport. This attempt, however, did not unveil the molecular identify of the Ca 2ϩ influx mechanism. Alternatively, investigators have focused on homology-based cloning strategies using sequences of previously described voltage-gated Ca 2ϩ channels (21, 22, 397, 443) , but also this approach did not result in the identification of the apical Ca 2ϩ entry transporter. Subsequently, functional expression cloning using a rabbit primary CNT/CCD cDNA library in Xenopus laevis oocytes was applied by Hoenderop (178, 257) .
To study the functional characteristics of this new Ca 2ϩ channel, TRPV5 was initially heterogeneously expressed in Xenopus laevis oocytes and later in human embryonic kidney (HEK293) cells. Functional data on TRPV5 include 45 Ca 2ϩ uptake, electrophysiology using voltage-clamp and patch-clamp experiments, and fluorimetric measurements (see sect. IV). In short, the channel was inhibited in order of potency by La 3ϩ Ͼ Cd 2ϩ Ͼ Mn 2ϩ . Permeability to Na ϩ was negligible in the situation where Ca 2ϩ and Na ϩ were both present, whereas Ba 2ϩ and Sr 2ϩ did not affect the Ca 2ϩ influx. These experiments unequivocally demonstrated that TRPV5 exhibits the defining properties of Ca 2ϩ influx in Ca 2ϩ -transporting epithelia. Subsequently, Hediger and co-workers (257, 304) applied the functional expression cloning technique and identified the Ca 2ϩ transporter 1 (CaT1 or recently renamed as TRPV6) from rat intestine, which shares 80% amino acid identity with TRPV5 (note: TRPV5 is also known in the literature as ECaC, ECaC1, and CaT2, whereas TRPV6 has been named previously CaT1, ECaC2, and CaT-like). Electrophysiological studies demonstrated that the characteristics of TRPV6 are comparable to those measured for TRPV5, but its expression pattern is more ubiquitous (see sect. IV). The functional properties of TRPV5 and TRPV6 are in line with those of epithelial Ca 2ϩ (re)absorption, providing the first evidence that these transporters are the anticipated Ca 2ϩ influx proteins initiating the process of transcellular Ca 2ϩ transport, which is described in detail in section IV (Fig. 1) (175, 302) . (218) . Depending on the vitamin D state, the cytosolic calbindin-D concentration can reach values in the submillimolar range, which is indeed sufficient to fulfill the above-mentioned functions (see sect. VIA) (38, 106) .
Previously, a homozygous mutant of calbindin-D 28K gene-knockout mice was generated by gene targeting which developed normally (3, 23, 361, 362 The calbindins, like CaM, belong to a group of intracellular proteins that bind Ca 2ϩ with high affinity and undergo structural changes upon binding (33) . Each calbindin is encoded by a separate gene, and there is no direct association between the two genes. In fact, nature has produced a wide variety of EF-hand Ca 2ϩ -binding proteins (i.e., calbindin-D 9K , calbindin-D 28K , CaM, parvalbumin, S100, troponin C) that display minor overall sequence homology (307) . An important functional feature of CaM and troponin is their ability to interact with and regulate the function of voltage-gated Ca 2ϩ channels in a Ca 2ϩ -dependent fashion. The ubiquitously expressed CaM directly interacts with an IQ motif present in the carboxy termini of these channels where it functions as a Ca 2ϩ sensor (358) . This IQ motif is, however, not present in TRPV5 and TRPV6. At present, it is unknown whether calbindin-D 9K or calbindin-D 28K could fulfill a similar Ca 2ϩ sensor function for which a specific interaction with TRPV5 and/or TRPV6 would be required. Freud and Christakos (118) reported an interaction of calbindin-D 28K with microsomal membranes in kidney (118) , whereas Shimura and Wasserman (351) showed that calbindin-D 28K is associated with purified chicken intestinal brushborder membranes. Together with the striking colocalization of calbindin-D 9K and/or calbindin-D 28K in all TRPV5/ 6-expressing tissues, this suggests a functional interaction between these two proteins. Future experiments are needed to delineate whether the function of calbindin is restricted to its buffer capacity maintaining low Ca 2ϩ concentrations in close vicinity of the channel mouth or whether a physical interaction between calbindin and TRPV5/6 is needed to exert a direct regulatory function.
C. Extrusion Mechanisms
The efflux of Ca 2ϩ occurs against a considerable electrochemical gradient, and two Ca 2ϩ transporters have been located in the basolateral membrane of absorptive cells to extrude Ca 2ϩ , i.e., a Na ϩ /Ca 2ϩ exchange mechanism (NCX) and a Ca 2ϩ -ATPase (PMCA).
The Na ϩ /Ca 2ϩ exchanger
To date, three genes for NCX, designated NCX1, NCX2, and NCX3, have been identified in mammals. Similarities between these proteins include a homology of ϳ70% sequence identity, the presence of an amino-terminal signal sequence, two sets of multiple transmembrane ␣-helices near the ends of the protein, and a large intracellular loop (46, 340) . Splicing of RNA transcripts is a general characteristic of the NCX genes in mammals to generate diversity. Reilly and Shugrue (325) published the sequence of the rabbit kidney NCX1, and in kidney the expression of this transporter is restricted to the distal part of the nephron where it is predominantly localized along the basolateral membrane (40, 171, 240) . NCX1 is widely distributed in many different mammalian tissues, whereas NCX2 and NCX3 are only expressed in brain and skeletal muscle (236, 275) . Unfortunately, specific inhibitors of NCX1 are not available to substantiate the relative importance of this exchanger for overall Ca 2ϩ reabsorption. Bindels and co-workers (39, 391) demonstrated that NCX1 is the primary extrusion mechanism, whereas only a minor amount of Ca 2ϩ in the distal tubular cells is extruded by the plasma Ca 2ϩ pump. NCX1 is also expressed in the basolateral membrane of the enterocytes (164, 210, 387) . In fish enterocytes, NCX appears to be the main mechanism by which transcellular Ca 2ϩ fluxes are extruded from the cells at the basolateral surface, whereas in mammals PMCA is the predominant extrusion mechanism (115, 164, 337, 387) . Together these functional studies suggest that in kidney, basolateral Ca 2ϩ extrusion is mainly carried out via NCX1, whereas Na ϩ /Ca 2ϩ exchange seems of minor importance in the small intestine. Recently, it was demonstrated that targeted deletion of NCX1 results in NCX1-null embryos that do not have a spontaneously beating heart and die in utero (219, 327) . Therefore, this animal model is, unfortunately, not suitable to verify the importance of NCX1 in renal epithelial Ca 2ϩ transport. In addition, several K ϩ -dependent Na ϩ -Ca 2ϩ exchangers (NCKX) have been described (46, 308) . Northern blot analysis demonstrated that some isoforms [i.e., NCKX4 (235) and NCKX6 (65)] of this family are expressed in epithelia including small intestine and kidney. Ubiquitous expression of these exchangers in various tissues suggests a key role in regulating intracellular Ca 2ϩ homeostasis in mammalian cells. It remains to be established whether these transporters play a role in epithelial Ca 2ϩ transport.
Regulation of NCX
Kimura et al. (212) were the first to directly measure a NCX current. Their experiments were carried out in guinea pig cardiac myocytes and provided evidence that the NCX exchanger actually generates a measurable membrane current in which the exchanger can translocate a net positive charge across the plasma membrane (100). The stoichiometry of NCX has been investigated by several groups, and calculations varied from 3 (266, 267) , indicating that this transporter is electrogenic. Comprehensive functional studies in oocytes and mammalian cell systems indicated that NCX is regulated by several factors including the membrane potential, PKC activation, protons, nucleotides, and calciotropic hormones (46) . Interestingly, it has been shown that NCX1 is regulated by PTH. Functional data demonstrated that PTH markedly stimulates Ca 2ϩ reabsorption in the distal part of the nephron primarily by augmenting NCX1 activity via a cAMP-mediated mechanism.
However, the exact mechanism by which PTH activates the exchanger remains controversial. Initial experiments suggested that the kidney isoform of NCX1 is poorly activated by PKA (161) . In another study, it was found that PTH does not affect the intracellular Ca 2ϩ concentration (312) , indicating that the activation of NCX1 cannot be explained by increased substrate availability. Moreover, it was postulated that PTH increases Cl Ϫ conductance in DCT cells leading to decreased intracellular Cl Ϫ activity and membrane hyperpolarization (137) . Hyperpolarization of the basolateral membrane will increase the Na ϩ /Ca 2ϩ exchange rate. Therefore, coactivation of apical Ca 2ϩ entry through TRPV5 occurs under conditions that are favorable for basolateral Ca 2ϩ extrusion (see also sect. IV). Other studies on isolated basolateral membrane vesicles implied that the PTH-induced rise in the intracellular Ca 2ϩ concentration is not required for the stimulatory effect of PTH (195) . Whether PTH stimulation affects expression of the NCX1 mRNA or the protein itself is not known. In addition to PTH, the calciotropic hormone 1,25-(OH) 2 D 3 also regulates the renal expression of NCX1. Studies in vitamin D-deficient knockout models showed an impressive downregulation of NCX1 mRNA that could be normalized by 1,25-(OH) 2 D 3 supplementation (sect. VI) (169) . In these animal models there was no significant downregulation of PMCA in line with a primary role of NCX in Ca 2ϩ extrusion. These findings point to a supportive role of the exchanger in vitamin D-stimulated Ca 2ϩ reabsorption.
PMCA
PMCAs are high-affinity Ca 2ϩ efflux pumps present in virtually all eukaryotic cells, wherein they are responsible for the maintenance and resetting of the resting intracellular Ca 2ϩ levels (45) . Four genes encode separate isoforms designated PMCA1-4. In addition, alternative splicing of the transcripts yields a large variety of splice variants differing mainly in their carboxy-terminal amino acid sequence (365, 369) . PMCAs are a universal system for the extrusion of Ca 2ϩ in cells. In kidney, PMCA is, in contrast to NCX, present in all nephron segments with highest expression in the basolateral membrane of cells lining the distal part of the nephron. Compared with other nephron segments, the distal convoluted tubule (DCT) possesses the highest Ca 2ϩ -ATPase activity (95) and exhibits the strongest immunocytochemical reactivity for PMCA protein expression (48, 49, 245 ). Studies at the transcript level using RT-PCR and advanced tissue microdissection techniques indicated that all four PMCA isoforms are distinctively expressed in the kidney, and variable abundance of the individual isoforms along the different regions of the nephron has been documented (369) . Other studies using RT-PCR on whole kidney RNA as well as studies at the protein level have been controversial but suggested that PMCA1 and PMCA4 are the major isoforms expressed in the kidney, while PMCA2 and PMCA3 may be minor components (246) . Based on the fact that PMCA1 and PMCA4 are widespread, while PMCA2 and PMCA3 are more tissue specific, it has been suggested that PMCA1 and PMCA4 are housekeeping isoforms involved in the maintenance of cellular Ca 2ϩ homeostasis (365) . At variance with this conclusion is the observation that PMCA1b transcripts were definitely observed in rabbit CNT and CCD, whereas expression of the PMCA2 isoform was not (171, 213). In addition, Kip and Strehler (213, 214) (39) .
IV. EPITHELIAL CALCIUM CHANNELS
A. Molecular Diversity TRP channel proteins constitute a large and diverse family of proteins that are expressed in many tissues and cell types (74, 256) . The large functional diversity of TRPs is reflected in their diverse permeability to ions, activation mechanisms, and involvement in biological processes ranging from pain perception to male aggression. Mammalian homologs of the Drosophila TRP gene encode a family of at least 20 ion channel proteins (Fig. 2) . They are widely distributed in mammalian tissues, but most of their specific physiological functions are largely unknown. The molecular structure that is conserved among all members of the TRP family is a channel subunit, containing six TM spanning domains and a pore region loop, that most probably assemble into tetramers to form unique ion channels allowing the influx of cations into cells (Fig. 3A) (polycystins, PKD-type), TRPA (for ankyrin), TRPML (for mucolipin), and the more distant subfamily TRPN (N for "nomp" no mechano-receptor potential). ANKTM1, a new member of the TRP ion channel family recently implicated in the detection of noxious cold, is sufficiently different from members of the other TRP subfamilies to warrant assigning this protein to a new subfamily, referred to as TRPA (201, 368) . While there is only one mammalian TRPA member, there are four in flies and two in worms (74, 77). To maintain consistency with the rest of the TRP nomenclature, it is recommended to refer to ANKTM1 as TRPA1 in future studies as suggested and approved by the HUGO nomenclature committee. Polycystic kidney disease is an autosomal-dominantly inherited disease causing progressive development of cysts in the kidney and liver (268, 269) . Nearly all cases result from mutations in either PKD1 or PKD2 genes, both of which encode proteins of the TRP family. PKD1 and PKD2 are usually lumped together in the TRPP branch, but the two groups have a markedly different molecular architecture and represent distinct phylogenetic branches of the superfamily. PKD1 is a very large protein of 12 TM segments, whereas PKD2 has the predicted topology of the TRP channel consisting of 6 TM spanning domains and clearly conduct ions (156) . Importantly, TRPP channels are mainly expressed in ciliated epithelial cells (270) .
Sequence alignments revealed that TRPC, TRPM, and TRPV, but not the TRPP channels, contain a characteristic six-amino acid motif located in the carboxy terminus (41) . An intriguing subfamily within the TRP superfamily is the TRPV subfamily consisting of six members. This group of channels includes TRPV1-4, which respond to heat, osmolarity, odorants, and mechanical stimuli, whereas epithelial Ca 2ϩ channels TRPV5-6 have been implicated in maintaining the body Ca 2ϩ balance by facilitating Ca 2ϩ (re)absorption in kidney and small intestine (175, 180, 302) . The epithelial Ca 2ϩ channel family is restricted to two members, and genomic cloning demonstrated that these Ca 2ϩ channels are transcribed from distinct genes rather than being splice variants (181, 301) . TRPV5 and TRPV6 are juxtaposed on the human chromosome 7q35 with a distance of only 22 kb, which suggests an evolutionary gene duplication event. The same situation was observed in the mouse genome in which TRPV5 and TRPV6 are localized on chromosome 6 in a region that is syntenic to human chromosome 7q33-35 (180, 301) . There is one other example found as a direct repeat of two homologs TRP channels. Comparable to the TRPV5/6 couple, TRPV3 is located juxtaposed the TRPV1 gene at a distance of 7.5 kb (41) . To date, TRPV5 and TRPV6 have been cloned from many species including rabbit, rat, mouse, and human (181) . The identified sequences exhibit an overall homology of ϳ75%. Strikingly, several domains in TRPV5/6 are completely conserved within these species including the core structure of the protein consisting of 6 TM segments and the pore region, ankyrin repeats, PDZ motifs, and putative PKC phosphorylation sites, of which three are conserved among all identified TRPV5/6 channels (Fig. 3A) . Detailed sequence analysis of TRPV5 and TRPV6 revealed the identification of several putative phosphorylation sites including PKC, PKA, and cGMPdependent kinase (89). For instance, in rabbit TRPV5, two combined putative phosphorylation sites for PKA and cGMP-dependent kinase (S669 and T709) were originally identified (178) . However, these predicted phosphorylation sites are not conserved in other species or in TRPV6. This is in contrast to the putative PKC phosphorylation sites of which three are conserved within the complete TRPV5/6 subfamily ( Fig. 3A) (181) . However, the physiological relevance of the conserved PKC sites is not clear, since mutations of these putative regions did not affect channel activity in HEK293 cells (Hoenderop and Bindels, unpublished data). To date, no information is available about the phosphorylation of TRPV5 and TRPV6. In addition, TRPV5 and TRPV6 contain PDZ motifs and ankyrin repeat domains in the amino-terminal region, which are also present in a diverse range of receptors and ion channels including the TRP superfamily. PDZ motifs are recognized by PDZ domains that are modular protein interaction domains playing a role in protein targeting and protein complex assembly (292) . There is evidence that they can regulate the functions of their ligands in addition to serving as scaffolds. Although binding to carboxy-terminal motifs appears to be the typical mode of interaction, PDZ domains could also interact with internal motifs that are present in TRPV5/6. In general, ankyrins link transporters and cell adhesion molecules to the spectrinbased cytoskeletal elements in specialized membrane domains (197) . Neural-specific isoforms of ankyrin have been demonstrated to participate in the maintenance and targeting of ion channels to subcellular regions in cells (217) . So far, no PDZ domain-or ankyrin domain-interacting proteins have been identified.
B. Ion Selectivity/Gating Mechanisms

Basic biophysical properties
The conspicuous biophysical hallmarks of TRPV5, which are also representative for TRPV6, are shown in Figure 4 (181, 444) . In HEK293 cells heterogeneously expressing TRPV5, currents through TRPV5 can be activated under conditions of high intracellular buffering of Ca 2ϩ by hyperpolarizing voltage steps. In the absence of divalent cations, large inward currents are observed, which show a typical time-dependent increase ("gating") and are constant over more than 1 min (Fig. 4A) up to 100 M reduces the current amplitudes through TRPV5/6, and 2) an increase from an extracellular Ca 2ϩ concentration of 100 M up to 30 mM or higher enhances the current again. This finding is reminiscent of the anomalous mole fraction behavior described previously for L-type voltage-gated Ca 2ϩ channels (4, 85, 163) . In analogy to L-type Ca 2ϩ channels, permeation through TRPV5/6 can by described by "repulsion" pore models considering a pore consisting of two high-affinity binding sites, whereby the double occupation of the two binding sites by either Na ϩ or Ca 2ϩ provides the "drive" for Ca 2ϩ conduction due to mutual repulsion of the two cations (403, 406) or by a three binding-site model in which two low-affinity sites flank a high-affinity binding site for Ca 2ϩ (181, 403, 406) . The current through TRPV5/6 is carried exclusively by Ca 2ϩ at extracellular Ca 2ϩ concentrations exceeding 10 M. Figure 5 shows single-channel data for Na ϩ currents through TRPV5 in inside-out patches. Current-voltage relationships show inward rectification also at the level of single channels. Conductance between Ϫ200 and Ϫ100 mV is ϳ75 pS, whereas between Ϫ100 and ϩ20 mV values were obtained ofϳ35 pS (Fig. 5A ). So far, no reliable single-channel measurements have been performed in the presence of extracellular Ca 2ϩ . Ensembled currents show a similar time course as macroscopic currents including a gating phase at the beginning of the hyperpolarizing voltage step (Fig. 5B) . The range of single-channel conductances for monovalent cations are all in a similar range between 40 and 70 pS and are obviously, although not compared in detail under identical condition, similar for TRPV5 and TRPV6 (285, 402, 444) . These values are important in regard to the controversy of whether TRPV6 might form the CRAC pore (see below). Another typical feature of currents through TRPV5/6 is the inactivation at negative potentials (Fig. 6 ). This inactivation is nearly complete if Ca 2ϩ is the charge carrier and is delayed when Ba 2ϩ substitutes Ca 2ϩ (Fig. 6A) . Currents of monovalent cations through TRPV5/6 do not inactivate. This feature is typical for a Ca 2ϩ -dependent component of inactivation. Repetitive stimulation of TRPV5/6 currents by short hyperpolarizing pulses consequentially result in a decay of the current (Fig. 6B ). The respective current-voltage relationships are shown in Figure 6 , C and D. The slow recovery from inactivation in divalent cation-free solution after the Ca 2ϩ -dependent decay is a further typical hallmark of TRPV5/6 channels. The time to 50% recovery from inactivation, dependent on the size of the Ca 2ϩ inward currents, is in the range of 1-2 min for TRPV5 and between 40 and 60 s for TRPV6.
Although all the above-described structural aspects and basic electrophysiological properties of TRPV5 and TRPV6 are rather similar, some differences remain which concern permeability of divalent cations, kinetics of Ca 2ϩ - CALCIUM ABSORPTION ACROSS EPITHELIA dependent inactivation, and recovery from inactivation ( Fig. 7) . Interestingly, these typical differences could be explained by sequence differences between TRPV5 and TRPV6. Ba 2ϩ permeates TRPV5 better then TRPV6, e.g., the current ratio I Ba /I Ca is ϳ0.9 for TRPV5, but only 0.4 for TRPV6. TRPV6 clearly shows a fast component of inactivation, which is less obvious for TRPV5, e.g., time to 10% inactivation at hyperpolarizing steps to Ϫ100 mV is ϳ125 ms for TRPV5 but only ϳ40 ms for TRPV6. More dramatic are the kinetic differences when Ba 2ϩ is the charge carrier. Fast inactivation is about twofold prolonged when Ca 2ϩ is substituted by Ba 2ϩ for TRPV5, but ϳ20 times for TRPV6 ( Fig. 8 ) (281) . Interestingly, the structural determinants of these differences seem not to be located in either the amino or carboxy terminus, but in the TM2-TM3 linker. Swapping of the TM2-TM3 linker of TRPV6 to TRPV5 confers the kinetic and permeation phenotype of TRPV6 to TRPV5, whereas swapping of the amino or carboxy termini is ineffective (Fig. 7 , A and B) (281) . Interestingly, this first intracellular loop is entirely encoded by one exon and could, therefore, provide an example of how a single exon may alter function (302) . Furthermore, functional differences concern the recovery from Ca 2ϩ -dependent inactivation, which is about three times slower for TRPV5 compared with TRPV6 (181) . Changes in the inactivation phase of TRPV6 have been reported by mutations of the histidine residue H587 in the carboxy terminus close to TM6 of TRPV6, which is not present in TRPV5 (375) . This residue might be involved in the fast inactivation of TRPV6 (302, 375) . Also, some striking pharmacological differences are present, e.g., ruthenium red is a 100-fold more potent blocker for TRPV5 than TRPV6 (IC 50 ϳ9 M for TRPV6 but ϳ100 nM for TRPV5) (Fig. 7C) . TRPV5 is about four times more sensitive to block by Cd 2ϩ than TRPV6 (IC 50 ϳ70 nM for TRPV5 but ϳ260 nM for TRPV6) (182).
Pore properties
TRPV5 and TRPV6 are so far the only known highly Ca 2ϩ -selective channels in the TRP superfamily. This unique permeation property is also not conserved in the TRPV subfamily, which shares the highest homology with TRPV5/6. TRPV1-4 are, however, all Ca 2ϩ and Mg 2ϩ permeable, but discriminate much less between divalent and monovalent cations, e.g., the relative selectivity for Ca 2ϩ and Mg 2ϩ over Na ϩ is between P Ca /P Na ϭ 1-10 (TRPV1-TRPV4) and P Mg /P Na ϭ 2-3 (only measured for TRPV4) (32, 155, 287, 411 ). TRPV5/6 display P Ca /P Na values of Ͼ100. Permeation of monovalent cations is Na (181, 285, 286, 404, 406) . This refers to an Eisenman sequence X for a strong field-strength binding FIG. 5. Single-channel currents through TRPV5 channels. A: Na ϩ currents through TRPV5 channels in cellattached patches. Cells were zeroed in an isotonic extracellular K ϩ solution. Pipette solution contains 140 mM Na ϩ in the absence of Ca 2ϩ and Mg 2ϩ , 5 mM EDTA. Two consecutive sweeps are shown for potentials. From amplitude histograms, single-channel current-voltage relationships were constructed (I-V). Conductance was measured from the I-V slope between Ϫ200 and Ϫ100 mV and Ϫ100 and ϩ20 mV. Estimation of the single-channel conductance is 75 and 35 pS, respectively. Note that also at the singlechannel level inward rectification occurs. B: ensemble-averaged current from 82 sweeps for a voltage step from ϩ20 mV to Ϫ100 mV. Note the similarities between ensemble-averaged current and whole cell currents. Increasing the time resolutions (right) unmasks a slow gating behavior at the single-channel level as shown in the whole cell experiment step. (From B. Nilius, unpublished data.) site (181, 285, 286, 406) . For TRPV6, a sequence of K ϩ Ͼ Na ϩ Ͼ Li ϩ , e.g., Eisenman V or VI (304), has been reported which, however, seems to be unlikely given the identical pores of TRPV5/6. For divalent cations, a permeation sequence of Ca 2ϩ Ͼ Ba 2ϩ Ͼ Sr 2ϩ Ͼ Mn 2ϩ has been reported (181, 305, 404, 406) .
A striking and important feature of TRPV5/6 channels is the open pore blockage by intracellular Mg 2ϩ ( Fig. 9 ) (409, 410) . In the absence of extracellular Ca 2ϩ , hyperpolarizing voltage steps (prestep, Fig. 9A ) activate inward currents with a slowly rising phase ("gating") ( Fig. 9B ). If after complete opening of the channels at negative potentials steps are applied to different test potentials, inward, but not outward, currents can be observed, indicating that TRPV5/6 channels nearly completely rectify. The typical current-voltage relationships, shown in Figure 9D , indicate that at negative potentials the intracellular Mg 2ϩ concentration is ineffective and also an intrinsic rectification remains in the absence of Mg 2ϩ . , gating and voltage dependence disappear, whereas rectification is still present, but diminished (Fig. 9C ). An open pore blockage by intracellular Mg 2ϩ explains the following findings: at depolarizing potentials, Mg 2ϩ moves towards the pore, thereby plugging the permeation pathway for monovalent ions. Unblock occurs at hyperpolarizing voltages. At very large depolarization, Mg 2ϩ is pushed through the pore, which results in a partial unblock of the channels (increased apparent P o , Fig. 9E ). These results are crucial to understand the pore properties of TRPV5/6.
Significant progress in the identification of the molecular determinants of TRP channel pores and the understanding of the high selectivity for Ca 2ϩ has been particularly achieved for TRPV5 and TRPV6 channels (286, 404, 406, 409, 410) . Structural differences in the channel pore explain the striking permeation differences in the TRPV subfamily. Figure 10A shows an amino acid sequence alignment of the putative pore regions of the three mammalian TRPV channels. Based on structural similarity with the selectivity filter of the potassium channel KcsA ("signature sequence" TXXTXGYGD) (96), the structural determinant of the low Ca 2ϩ -selective TRPV1-4 channels is the GM(L/M)GD motif in TRPV1-4 (287, 411, 446) . The sequence similarities may indicate conserved pore structures for these cation channels. Importantly, this motif is missing in TRPV5/6. Instead, we have demonstrated that the molecular determinants of the Ca 2ϩ selectivity and permeation of TRPV5/6 reside at a single aspartate residue (TRPV5-D542 and TRPV6-D541) present in the pore-forming region ( Fig. 10B) (286, 409) . Neutralization of these residues not only affects the high Ca 2ϩ selectivity of TRPV5/6, but also drastically reduces their sensitivity to extracellular Cd 2ϩ and abolishes Mg 2ϩ -dependent voltage-dependent gating of these channels (409, 410, 412) . It thus appears that high Ca 2ϩ selectivity in TRPV5 and TRPV6 depends on a ring of four aspartate residues in the channel pore, similar to the ring of four negative residues (aspartates and/or glutamates) in the pore of voltage-gated Ca 2ϩ channels (Fig. 10B ). Likely, D542/D541 is the narrowest part of the selectivity filter with a diameter of ϳ5.2 Å and forms part of the highaffinity binding site for Ca 2ϩ and Mg 2ϩ (408) . A detailed analysis of the structure of the TRPV5 and TRPV6 pores has now been published (94, 407) . To obtain insight in the pore architecture of TRPV6, a pore diameter of 5.4 Å was estimated from permeation studies. Mutating D541, a residue involved in high-affinity Ca 2ϩ binding, altered the apparent pore diameter, indicating that this residue lines the narrowest part of the pore and is part of the selectivity filter (407) . Pore lining amino acids were determined by cysteine scanning mutagenesis (SCAM). Cysteines introduced in a region preceding D542 for TRPV5 and D541 for TRPV6 displayed a cyclic pattern of reactivity to cysteine reacting agents indicative of a pore helix. The location of the cation-selective filter was identified at the outer part of the pore helix. The pattern of covalent modification of cysteines supports a KcsA homology-based three-dimensional model (96). The external vestibule in TRPV5 and TRPV6 may build up the three structural domains consisting of a coiled structure that is connected to a 15-amino acid pore helix followed by the selectivity filter (probably a coiled structure with D542 and D541 as the narrowest part) and another coiled structure before the beginning of TM6. This is the first structural model of a TRP channel pore.
The pore region of TRPV5/6 contains additional negatively charged amino acids (Fig. 10A ) that only have minor effects on the Ca 2ϩ permeation properties. In another study, the role of D542 for blockage of monovalent currents through TRPV5 by Ca 2ϩ and Mg 2ϩ was supported, however, not for determining Ca 2ϩ permeability (196) . However, all of our data including recent findings from concatemers and a detailed study of TRPV6 pore properties clearly demonstrated the role of D542/D541 for Ca 2ϩ selectivity (182, 286, 408, 409, 412) . Another surprising result was the triple pore mutant F534/E535/L536 (84). This mutant has been reported to induce nonfunctional channels. However, any mutation of E535 was without effect for TRPV5 or TRPV6 permeation (196, 286, 408) .
Mechanism of high Ca 2ϩ selectivity
Our understanding of the pore properties of TRPV5/6 refers to the following mechanism of high Ca 2ϩ selectivity, which is similar to the mechanisms of permeation by binding as proposed earlier for L-type Ca 2ϩ channels (165, 381) . Under Ca 2ϩ -free conditions, Mg 2ϩ will bind at a site within the channels, which is mainly determined by D542/ D541. At low driving forces, e.g., less negative membrane potentials, the driving force is not sufficient to move Mg 2ϩ out of this binding well and the channel is blocked. At hyperpolarization, Mg 2ϩ will be moved from this highaffinity site, thereby allowing monovalent cations to permeate the channels. Vice versa, at very positive membrane potentials, Mg 2ϩ will move through the pore towards the extracellular space. Because of the higher affinity of the binding site for Ca 2ϩ versus Mg 2ϩ , Ca 2ϩ will outnumber Mg 2ϩ at this site and is now blocking the pore for a movement of monovalent cations. If the inward driving force is high enough to remove Ca 2ϩ from the high-affinity site, a fast inward permeation occurs supported by the low-affinity sites, which flank the highaffinity Ca 2ϩ binding site. All our data so far support a crucial role of D542/D541 for establishing this functionally important site in the channel pore. The same mechanism has been reevaluated for tetrameric channels (182) . Importantly, mutation of only one aspartate residue in the tetrameric channels already results in loss of Ca 2ϩ selectivity and voltage dependence. Obviously, D542/D541 reflects a dominant effect on the unique pore properties of these Ca 2ϩ channels.
Rectification
A nearly complete inward rectification is a further hallmark of the TRPV5/6 channels in addition to the high Ca 2ϩ selectivity. This inward rectification is only partially due to blockage by Mg 2ϩ , which is removed by hyperpolarization. Thus the most prominent part of rectification remains in the absence of intracellular Mg 2ϩ and is not due to blockage by endogenous polyamines. This intrinsic rectification of the channels is, however, dramatically reduced by neutralization of D542/D541, indicating that this site is also involved in rectification (409).
Gating
In the generally used overexpression systems, TRPV5/6 are constitutively open at a low intracellular Ca 2ϩ concentration and negative voltage. The above-described mechanism of removing channel blockage by Ca 2ϩ or Mg 2ϩ is necessarily part of the gating mechanism. We cannot exclude other mechanisms that might influence gating of TRPV5/6. However, essential prerequisites of channel opening are 1) low intracellular Ca 2ϩ to remove Ca 2ϩ -dependent inactivation; 2) hyperpolarization, e.g., an increased driving force for the permeating cation which must be sufficient to move Ca 2ϩ from the high affinity site; and 3) removal of the open pore blockage by Ca 2ϩ and Mg 2ϩ .
C. Modulation of Channel Activity
Intracellular Ca 2ϩ
TRPV5 and TRPV6 are subject to Ca 2ϩ -dependent feedback inhibition (282, 404) . Both channels rapidly inactivate during hyperpolarizing voltage steps, and this inactivation is reduced when Ba 2ϩ or Sr 2ϩ was used as charge carriers. This inhibition was dependent on the extracellular Ca 2ϩ concentration and occurred also in cells buffered intracellularly with 10 mM BAPTA. Currents also disappeared during repetitive activation by FIG. 10 . Structure of the TRPV5/6 pore. A: alignment of the pore regions of TRPV4, -5, and -6 and the potassium channel KcsA (accession numbers AAG17543 for TRPV4, CAB40138 for TRPV5, AAD47636 for TRPV6, and S60172 for KcsA). The boxed sequences represent the putative selectivity of all channels. The amino-terminal part of this pore structure likely represents a putative pore helix. B and C: model for the TRPV6 pore region, based on the KcsA structure. Views of the structure are shown, looking sideways at two opposite subunits (left) or looking down from the external solution to the complete homotetrameric channel (right). At the narrowest point, formed by the acidic side chain of Asp-541 (orange), the pore has a diameter of 5.4 Å . Blue residues correspond to the residues in TM5 and TM6 (TM1 and TM2 in KcsA), whose accessibility was not tested in this study. Amino acids that were subjected to SCAM analysis (residues P526 to D547) are colored in green, yellow, red, or gray: residues in red reacted rapidly to Ag ϩ (reaction rate Ͼ5 ϫ 10 6 M Ϫ1 · s Ϫ1 ), residues in yellow reacted with Ag ϩ at a rate Ͻ5 ϫ 10 6 M Ϫ1 · s
Ϫ1
, and residues in green did not show significant reactivity to Ag ϩ . Residues where cysteine substitution resulted in nonfunctional channels are marked in gray. The figure was prepared using DS ViewerPro 5.0 (Accelrys), based on the coordinates of KcsA.
short hyperpolarizing pulses. This decay of the current was significantly diminished when Ca 2ϩ was replaced by Ba 2ϩ as charge carrier and abolished when extracellular Ca 2ϩ was lowered to 1 nM, again indicating that a Ca 2ϩ -operated process inhibits TRPV5/6 activity. These regulatory processes were strongly influenced by the surrounding Ca 2ϩ concentrations. Elevation of the extracellular Ca 2ϩ concentration significantly increased the rate of current decay. Ca 2ϩ influx is a prerequisite for this phenomenon because the Ca 2ϩ -impermeable D542A mutant lacks a monovalent current decay in response to repetitive stimulation (282) . These data suggest that the TRPV5/6 channels are downregulated by Ca 2ϩ influx through the channel and thus likely by increasing the Ca 2ϩ concentration in a microdomain near the pore region, thereby inducing feedback inhibition of the channel. This could be a crucial mechanism for regulation of TRPV5/6 under physiological conditions. It was shown that this inhibition is highly Ca 2ϩ sensitive with calculated affinity values down to 100 nM. When measured directly in inside-out patches, half-maximal inhibition of TRPV5 currents occurred at ϳ200 nM (282) . With the consideration of the high-affinity mechanism of Ca 2ϩ -dependent TRPV5/6 inhibition, the presence of intracellular Ca 2ϩ buffer proteins such as calbindins will play an important role in the regulation of channel activity (173, 175, 181) .
Recovery from inhibition upon washout of extracellular Ca 2ϩ (whole cell configuration) or removal of Ca 2ϩ from the inner side of the channel (inside-out patches) is slow in both conditions. Half-maximal recovery was reached after 100 -135 s (282). The slow recovery of TRPV5 (and to a lesser extent TRPV6) from their Ca 2ϩ -induced inhibited state is an intriguing feature of both TRPV5/6 . Surprisingly, recovery is much slower than the inhibition, although this putative microdomain is accessible for intracellular Ca 2ϩ , and it does not correlate with the removal of intracellular Ca 2ϩ either, since full recovery occurs much later than restoration of the basal Ca The similar rates of recovery in whole cell and excised patch experiments might indicate that it is controlled by a complex consisting of pore and microdomain. Furthermore, these data suggest that other processes than rapid binding and slow dissociation of Ca 2ϩ could be involved and might hint to interaction with other regulatory proteins.
The molecular mechanism of this feedback inhibition remains, however, unclear at the moment. The first mechanistic insight into Ca 2ϩ -dependent inactivation of TRPV6 included a Ca 2ϩ -dependent binding of CaM to the carboxy terminus (Fig. 11, A and B) . (276 11D) . Detailed mutation analysis revealed that mutation of A650 and F651 decreased already the Ca 2ϩ sensitivity of TRPV5. C653X showed a decreased Ca 2ϩ sensitivity, comparable to G701X, while E649X lacked Ca 2ϩ -dependent inactivation (Fig. 11C) . Likely, cells expressing truncations shorter than E649 do not survive and could only be restored in the presence of the high-affinity blocker ruthenium red, suggesting that these truncations exhibited a deleterious Ca 2ϩ influx (288).
pH
It is well known that acidification of the apical medium inhibits transcellular Ca 2ϩ absorption across primary cultures of rabbit CNT and CCD cells (37) . It was, therefore, interesting to evaluate modulation of TRPV5 by pH. 45 Ca 2ϩ uptake in TRPV5 expressing Xenopus laevis oocytes is inhibited by acidification of the incubation medium (179) . Indeed, extracellular acidification reduced currents through TRPV5 carried by either monovalent or divalent cations, which was confirmed by Peng et al. (303) . Additionally, extracellular pH also affected current kinetics, extracellular Mg 2ϩ blockage, and Ca 2ϩ affinity. The gating component of monovalent cation currents through TRPV5 was delayed at alkaline pH and as well as blockage by extracellular Mg 2ϩ . Mg 2ϩ blockage of monovalent currents was shifted from an IC 50 of ϳ62 at pH 7.4 to ϳ300 M at pH 6.0 and ϳ40 M at pH 8.5, indicating that blockage of TRPV5 by extracellular Mg 2ϩ is reduced under more alkaline conditions. Blockage of monovalent cation currents through TRPV5 by Ca 2ϩ is less efficient at low pH (in the presence of 100 M extracellular Ca 2ϩ ϳ160 nM at pH 7.4 and ϳ5 M at pH 6.0) (405) . Both results indicate that Ca 2ϩ and Mg 2ϩ binding in the channel are weakened at higher proton concentrations. For L-type Ca 2ϩ channels and cyclic nucleotide-gated channels, it was suggested that protonation of a single glutamate residue in the pore region is responsible for the dramatic changes in divalent cation affinity for the channel with respect to variations in the extracellular pH (316, 328, 376) . This could be analogous for TRPV5 in which a single aspartate residue determines the Ca 2ϩ permeation and Mg 2ϩ blockage of the channel. Extrapolating the pH influence to the in vivo situation, this effect could at least in part provide the molecular basis of acidosis-induced calciuresis. Interestingly, the molecular mechanism of TRPV5 blockage by protons is mechanistically understood taking into account the pore structure described above. Mutation of the glutamate at position 522 to glutamine (E522Q) preceding the pore helix decreases inhibition of the channel by extracellular protons. Thus pH sensitivity is mainly mediated by glutamate at position 522 and may act as the "pH sensor" of TRPV5 (438) .
Pharmacology
Little is known about effective pharmacological tools to modulate TRPV5/6. Ruthenium red and econazole appeared to be the most effective inhibitors. TRPV5/6 are efficiently blocked by inorganic cations. (283, (303) (304) (305) 406) . The inorganic polycationic dye ruthenium red, which binds to phospholipids, inhibits TRPV5 and TRPV6 in a voltage-dependent manner. Blockage is attenuated at depolarizing potentials. Currents of monovalent cations through TRPV5 are blocked with an IC 50 of ϳ100 nM at Ϫ100 mV. Transcellular Ca 2ϩ transport in primary cultures of immunodissected rabbit CNT and CCD is inhibited in the same concentration range (283) . Antimycotic imidazoles such as econazole and miconazole are highly effective inhibitors with IC 50 values of ϳ1-2 M. These compounds block, however, voltage independent (283). Blockers of store-operated Ca 2ϩ entry channels (SOC), e.g., SKF96365 and 2-aminoethoxydiphenylborate (2-APB), are nearly ineffective for TRPV5 and TRPV6 (283, 336, 410) . Another SOC blocker, the adenyl cyclase inhibitor MDL 12330A (399), exerts a half-maximal inhibition of TRPV5 at ϳ20 M (283). Xestospongin, a noncompetitive inositol 1,4,5-trisphosphate receptor antagonist, seems, however, to block TRPV6 (402 TRPV1. Arginine-rich peptides, such as dynorphins, inhibit currents through TRPV1 (311). TRPV5 is, however, resistant to both dynorphin A and the fragment 10 consisting of the first 10 amino acid residues of dynorphin A. Also, blockers of protein tyrosine kinases such as tyrphostin B46 and genistein, CaM antagonists calmidazolium R24571 and trifluoperazine, and channel blockers such as mibefradil, quinidine, nifedipine, niflumic acid, and verapamil, have only small or no effects on TRPV5 activity (283) . Interestingly, some pharmacological tools differentiate between TRPV5 and TRPV6. Blockage by ruthenium red and Cd 2ϩ is much more sensitive for TRPV5 than TRPV6 (181, 182) . Blockage of TRPV6 by capsaicin has been described (84) that is ineffective for TRPV5 (Nilius, unpublished data).
D. CRAC and TRPV6
One of the still unsolved problems in channel physiology is the nature and the mechanism of activation of SOC. Twenty-four years ago Casteels and Droogmans (68) showed that depletion of agonist-sensitive intracellular stores stimulates the rate of Ca 2ϩ uptake from the extracellular solution in vascular smooth muscle cells. The first electrical measurement of SOC was achieved in mast cells, and this current was referred to as "calcium releaseactivated calcium current" (CRAC) (189) . CRAC is still the best-characterized SOC. It is a highly Ca 2ϩ -selective, inwardly rectifying channel; permeable to Ca 2ϩ , Sr 2ϩ , Ba 2ϩ , but not Mg 2ϩ ; exhibits anomalous mole fraction behavior; becomes permeable for monovalent cations in the absence of extracellular divalent cations; and is inactivated by an increase in the intracellular Ca 2ϩ concentration (300). These properties are reminiscent to the abovedescribed biophysical properties of TRPV5/6 except the activation by depletion of intracellular Ca 2ϩ stores. Recently, Yue et al. (444) reported that TRPV6 was activated by store depletion and manifests the pore properties of CRAC in RBL cells and might, therefore, be CRAC or at least part of the CRAC pore (444) . This store-operated mode could, however, only be observed in COS cells in a restricted posttransfection time window when the current density was lower than in other studies. A strong argument for TRPV6 being CRAC was at that time apparent identical single-channel conductance for monovalent cations (208) . It has also been reported in several forthcoming studies that a correlation between CRAC and TRPV6 exists: 1) an upregulation of CRAC channel was observed in RBL cells by transfection with TRPV6 (336); 2) in prostate cancer cells, which express TRPV6, antisense oligonucleotides downregulated TRPV6 and CRAC and antiandrogens unregulated both TRPV6 and CRAC (395) ; and 3) expression of a "dominant negative" pore mutant of TRPV6 in Jurkat cells, the already mentioned triple mutant F534A/E535A/L536A, attenuated endogenous CRAC (84). However, several features are incompatible with the proposed equality of the TRPV6 and CRAC or CRAC pores. Open pore blockage by intracellular Mg 2ϩ , which is a hallmark of TRPV5/6 gating (409, 410, 412) , is completely absent in CRAC. In fact, CRAC behaves like TRPV5/6 in the absence of intracellular Mg 2ϩ even when a high free intracellular Mg 2ϩ concentration is present (also Fig. 4 (182, 408 -410) . Recently, TRPV6 antisense and siRNA knockdown approaches inhibited TRPV6-derived currents in mast cells, but failed to inhibit CRAC currents. These results render it improbable that TRPV6 is a component of native CRAC channels in mast cells (203) . It seems, therefore, unlikely that even heteromultimers containing TRPV6 form the highly Ca 2ϩ -selective CRAC pore. More striking evidence against TRPV5/6 being CRAC comes now surprisingly from single-channel measurements. It has been recently shown that in extracellular solutions that are free of divalent cations and under conditions of reduced intracellular Mg 2ϩ , the dominant cation current in Jurkat and RBL cells is through a channel first termed MagNuM (magnesium-nucleotide-regulated metal cation current), which is conducted by the LTRPC7 channel (162) or also called MIC (Mg 2ϩ inhibited cation channels) (314) . These channels have a single-channel conductance for monovalent cations of ϳ45 pS as reported for TRPV6 by Yue et al. (444) . Because most of the studies on CRAC have used divalent-free solutions on either side of the membrane to study selectivity, the single-channel conductance of CRAC was misinterpreted by the one of MagNuM/MIC/TRPM7 which are activated by a decrease in intracellular Mg 2ϩ /Mg-ATP (162) . CRAC has indeed a single-channel conductance of ϳ0.2 pS (209, 220) rather than ϳ45 pS as TRPV6 (see also Refs. 16, 73, 313) . Interestingly, estimation of the pore diameter also resulted in rather different values. TRPV6 has a diameter of ϳ5.2 Å (408), whereas for CRAC a diameter of ϳ3.8 Å was estimated (313) .
However, other differences also exist including the striking permeation difference of CRAC and TRPV5/6 for Cs ϩ (Cs ϩ is much less permeable through CRAC than through TRPV5/6), the different time course of the monovalent currents through CRAC (inactivating) and TRPV5/6 (sustained), the striking differences in rectification (much less rectification for monovalent currents in CRAC than TRPV5/6) and effects of extracellular 2-APB (blockage of CRAC but even light potentiation of TRPV6) (for a review see Refs. 280, 410) . In addition, we have never observed any store-operated activation for TRPV5 or TRPV6. However, TRPV6 expression in HEK293 cells does result in a constitutive open channel, is not activated by ionomycininduced store depletion, and is inhibited by a rise in cytosolic Ca 2ϩ concentration independently of the posttransfection time (410) . Furthermore, TRPV6 seems not to be expressed in Jurkat cells, one of the preferred cells to study CRAC, and expression of TRPV6 in these cells does not reveal store-dependent properties (47) . CRAC is obviously not TRPV5/6. A modulator role for store-operated Ca 2ϩ influx cannot be excluded (75). As a bottom line, all Ca 2ϩ -permeable TRP channels contribute to changes in the intracellular Ca 2ϩ concentration and may, therefore, also affect store-operated processes. There is so far no TRP channels for which a consensus for being CRAC has been settled and at least TRPV5 or TRPV6 are very unlikely CRAC/SOC (74, 75).
E. Molecular Structure of TRPV5 and TRPV6
The oligomerization of TRPV5 and TRPV6 channels has recently been unraveled (182) . Cross-linking studies, coimmunoprecipitations, and molecular mass determination of TRPV5/6 complexes using sucrose gradient sedimentation showed that TRPV5 and TRPV6 form homoand heterotetrameric channel complexes. As described in section V, TRPV5 and TRPV6 are coexpressed in some tissues, which allows oligomerization of these channels in vivo. For instance, immunohistochemical data in kidney clearly demonstrated coexpression of TRPV5 and TRPV6 in the DCT (182) . However, coexpression of TRPV5 and TRPV6 in these tissues is until now only quantified at the mRNA level, indicating that TRPV6 is 100 -10,000 more expressed than TRPV5. Quantification at the protein level of both channels is certainly important to address the stoichiometry in vivo. Heteromeric complex formation can modify the activity of members of the TRP family. The Drosophila TRP and TRPL members were identified first, and it has been shown that these proteins form heteromultimeric channels associated in a supramolecular signaling complex with receptors and regulators including PKC, CaM, and the scaffolding PDZ domain containing protein InaD (13, 233) . Moreover, it has been shown for TRPC1 and TRPC3 that hetero-oligomers of these channels possess more distinctive properties than that of either channel alone (237) . In addition, Strubing et al. (370) demonstrated that TRPC1 and TRPC5 are subunits of a heteromeric neuronal channel. Both TRPC proteins have overlapping distributions in the hippocampus. Coexpression of TRPC1 and TRPC5 in HEK293 cells resulted in a novel nonselective cation channel with a voltage dependence similar to N-methyl-D-aspartate (NMDA) receptor channels, but unlike that of any reported TRPC channel. Other TRPCs exclusively assemble into homo-or heterotetramers within the confines of TRPC subfamilies, e.g., TRPC4/5 and TRPC3/6/7 (187) . Based on the ability of the TRPC channels to form functional homo-and heteromultimeric complexes, Tsiokas et al. (382) provided evidence that PKD2, which is functionally related to the TRPC proteins, interacts with TRPC1, suggesting a possible role of this protein in modulating Ca 2ϩ entry in response to G protein-coupled receptor activation and/or store depletion (382) . Within the TRPV family, the oligomeric structure of TRPV1 was studied by biochemical cross-linking, and the predominant existence of tetramers was suggested (207) . The principles of TRP channel formation provide the conceptual framework to address the physiological role of distinct TRP members. Likewise, hetero-oligomerization of TRPV5 and TRPV6 might influence the functional properties of the formed Ca 2ϩ channel. As TRPV5 and TRPV6 exhibit different channel kinetics with respect to Ca 2ϩ -dependent inactivation, Ba 2ϩ selectivity and sensitivity for inhibition by ruthenium red, the influence of the heterotetramer composition on channel properties was investigated (Fig. 7) . Concatemers were constructed consisting of four TRPV5 and/or TRPV6 subunits configured in a head-to-tail fashion (182) . A different ratio of TRPV5 and TRPV6 subunits in these concatemers showed that the phenotype resembles the mixed properties of TRPV5 and TRPV6. An increased number of TRPV5 subunits in such a concatemer displayed more TRPV5-like properties, indicating that the stoichiometry of TRPV5/6 heterotetramers influences the channel properties. Consequently, regulation of the relative expression levels of TRPV5 and TRPV6 may be a mechanism to fine-tune the Ca 2ϩ transport kinetics in kidney or other TRPV5/6-coexpressing tissues. The tetrameric organization of TRPV5/6 resembles that of the Shaker potassium channel, which is composed of four tandemly associated homologous domains (221, 234) . The clustering of four subunits is assumed to create an aqueous pore centered at the fourfold symmetry axis (Fig.  10B) (234) . This tetrameric architecture of TRPV5/6 implies that four of the aspartic residues [D542 (286), D541 (408)] form a negatively charged ring that functions as a selectivity filter for Ca 2ϩ in analogy with voltage-gated Ca 2ϩ channels (182) . Interestingly, Niemeyer and coworkers (102) identified the third ankyrin repeat being a stringent requirement for physical assembly of TRPV6 subunits. Deletion of this repeat or mutation of critical residues within this repeat renders nonfunctional channels that do not coimmunoprecipitate or form tetramers. It was proposed that the third ankyrin repeat initiates a molecular zippering process that proceeds past the fifth ankyrin repeat and creates an intracellular anchor that is necessary for functional subunit assembly (102). Protein crystallography of these channels will be the most chal-lenging approach to determine the molecular structure in the near future.
V. SITES OF EPITHELIAL CALCIUM TRANSPORT
The exchange of Ca 2ϩ between higher organisms and the environment takes place across epithelia, including the gastrointestinal tract, bone, kidney, and gills. Ca 2ϩ transport occurring in these Ca 2ϩ -absorbing epithelial tissues is realized by paracellular and transcellular Ca 2ϩ transport as outlined in sections II and III.
A. Kidney
The renal handling of Ca 2ϩ has been the subject of intensive investigation over the last years. The kidney plays an essential role in the maintenance of the Ca 2ϩ balance by regulating the Ca 2ϩ excretion of the body. On a daily basis, ϳ8 g of Ca 2ϩ is filtered at the glomeruli of which Ͻ2% is excreted into the urine. As a consequence, filtered Ca 2ϩ is extensively absorbed as it passes through the individual nephron segments.
Proximal tubule
The proximal tubules, including proximal convoluted (PCT) and proximal straight (PST) tubules, are responsible for absorbing the majority of Ca 2ϩ . Micropuncture studies have demonstrated that ϳ70% of the Ca 2ϩ is absorbed in these segments (99, 122, 374, 385) . Ca 2ϩ transport along the proximal tubule proceeds essentially as an isosmotic process that is based on early micropuncture studies demonstrating that Ca 2ϩ , Na ϩ , and water are absorbed in parallel (reviewed in Ref. 371) . This means that the majority of Ca 2ϩ reabsorption in these segments is energetically passive and follows the local Na ϩ reabsorption.
Limb of Henle
In the thin descending and ascending limbs of Henle, the permeability for Ca 2ϩ is very low, and basically we can conclude that significant net Ca 2ϩ transport does not occur in this segment (318, 331) . This low Ca 2ϩ permeability is particularly striking in view of the comparatively high permeability to Na ϩ and Cl Ϫ (331). Because these thin limbs of Henle do not transport Ca 2ϩ , the thick ascending limb of Henle (TALH) is responsible for the Ca 2ϩ reabsorption between the bend of the loop and the start of the DCT (14, 53, 56, 92, 93, 120, 129, 192, 274, 331, 372, 373, 432) . Approximately 20% of the Ca 2ϩ filtered at the glomeruli is absorbed in Henle's loop (371) . In several studies Ca 2ϩ reabsorption in cortical TALH was examined. Bourdeau and Burg (54) provided evidence that Ca 2ϩ transport was driven by the electrochemical gradient, indicative of a passive absorption process. Similar findings were described by Shareghi and Agus (343) , who concluded that Ca 2ϩ reabsorption in the TALH is passive and driven by the large lumen-positive membrane potential. In contrast, Imai (192) postulated an active Ca 2ϩ transport component in cortical TALH segments, whereas his studies in medullary TALH segments are more consistent with a passive mechanism. These findings were confirmed in mouse kidney by Friedman (120) , reabsorption, since mutations of PCLN-1 are present in patients with the hypomagnesemia hypercalciuria syndrome (HHS) (43) . In these patients, renal Ca 2ϩ reabsorption is impaired as expected. This study was the first to demonstrate that homozygous mutations of PCLN-1 result in a selective defect in paracellular divalent cation reabsorption in the TALH, with intact sodium chloride reabsorption ability in this segment. Altogether, this segment definitely plays a significant role in the process of Ca 2ϩ reabsorption, mainly due to paracellular Ca 2ϩ transport. The contribution of active Ca 2ϩ transport is, however, questionable (264).
DCT and CNT
The fine-tuning of Ca 2ϩ excretion in the kidney occurs in the distal part of the nephron and amounts to 15% of the filtered load of Ca 2ϩ (79). This section consists of DCT and CNT. The CNT lies just distal to the DCT, arising abruptly in rabbits and gradually in most other species (63, 80, 204, 240) . The CNT contains, in contrast to DCT, in addition to principal cells also intercalated cells. The relative contribution of these two segments to active Ca 2ϩ reabsorption appears to differ between the various species (38, 346 -349, 371) . In these nephron segments, Ca 2ϩ reabsorption occurs against the existing electrochemical gradient. Together with the fact that the tight junctions are relatively impermeable for Ca 2ϩ , this substantiates that Ca 2ϩ is reabsorbed in these segments through an active transcellular pathway. By comparing the fractional CALCIUM ABSORPTION ACROSS EPITHELIA Ca 2ϩ delivery at the beginning of the DCT and the final urine, early studies indicated Ca 2ϩ reabsorption in these segments (385) . Over the last years, several studies indicated that in most mammalian species the DCT is the primary nephron segment of active Ca 2ϩ transport. However, the exact sites for transcellular Ca 2ϩ reabsorption along the distal part of the nephron are still being questioned. Extensive studies revealed that the localization of the Ca 2ϩ transport proteins, including TRPV5, TRPV6, calbindins, NCX, and PMCA, is restricted to the late distal part of the DCT (DCT2) and the CNT (171, 240). Micropuncture investigations of Ca 2ϩ transport in the rat distal convolution (comprising DCT1, DCT2, CNT, and the initial CCD) aimed to distinguish between the first two (including DCT1, -2) and last two (including CNT and initial CCD) segments. Microperfusion studies by Costanzo and Windhager (78) showed similar Ca 2ϩ transport rates in these segments, whereas experiments by Greger et al. (154) suggested that transcellular Ca 2ϩ transport occurs predominately in CNT.
Transepithelial Ca 2ϩ transport depends on the activity of Ca 2ϩ -transporting proteins in the apical and basolateral plasma membranes and the cytosol of the epithelial cells. Loffing et al. (240) and several studies by Hoenderop and Bindels and co-workers (171, 279) demonstrated in the mouse coexpression of the Ca 2ϩ transport proteins including TRPV5, TRPV6, PMCA1b, NCX1, and calbindin-D 28K in DCT2 and CNT, with the highest immunochemical abundance in DCT2, and a gradual decrease along CNT (Fig. 12A) . The parallel axial reduction of apical TRPV5 and of basolateral Ca 2ϩ extrusion machinery, i.e., PMCA1b and NCX1, indicates a progressive decrease of transcellular Ca 2ϩ transport rates along CNT. TRPV5, PMCA1b, and NCX1 abruptly disappeared at the transition to the CCD, consistent with the notion that transcellular Ca 2ϩ transport is negligible in CCD (240) . A minority of cells along CNT lacked immunopositive staining for TRPV5 and the other Ca 2ϩ -transporting proteins. These negative cells were identified as intercalated cells (171, 240) . Taken together, these findings strongly suggest that, in the mouse, the major sites of transcellular Ca 2ϩ transport are DCT2 and, probably to a lesser extent, CNT. Whether Ca 2ϩ transport occurs in DCT1 of mice, and if so at which rate is unknown. The occurrence of weak immunostaining for NCX1 and PMCA1b would be in line with active Ca 2ϩ transport in this segment. At variance with the presence of these basolateral Ca 2ϩ -transporting proteins, TRPV5 and TRPV6 were not detectable in DCT1 (171, 240, 279) . This raises the question whether other apical Ca 2ϩ entry pathways might play a role in transcellular Ca 2ϩ transport in DCT1 or confirms the absence of an active transport process. The existence of such pathways in DCT has been suggested by RT-PCR data obtained from isolated rat tubules (443) and an immortalized mouse DCT cell line (12) . However, these cell preparations do not represent solely DCT1, and the corresponding findings should, therefore, be interpretated with great care. Combined micropuncture experiments, immunohistochemistry of the Ca 2ϩ transport proteins, and corresponding nephronspecific mouse knockout models are needed to investigate whether active Ca 2ϩ transport occurs in DCT1.
FIG. 12. Localization of TRPV5 and TRPV6 in kidney and small intestine. A: immunopositive staining for TRPV5 that is predominantly found along the apical membrane of the distal tubule in the mouse. Schematic overview of the expression of the Ca 2ϩ transport proteins in the kidney (bottom). B: immunopositive staining for TRPV6 that is typically observed along the mouse brush-border membrane of the duodenum. Schematic overview expression of the Ca 2ϩ transport proteins in the intestine is shown (bottom).
Collecting duct
The collecting duct is the last segment of the nephron and extends from the connecting tubule in the cortex through the outer and inner medulla to the tip of the papilla. It can be divided into at least three regions, based primarily on their localization in the kidney. These include CCD, the outer medullary collecting duct (OMCD), and the inner medullary collecting duct (IMCD). The collecting duct consists of principal cells that are responsible for salt and water reabsorption and intercalated cells that play a major role in H ϩ and HCO 3 Ϫ secretion. These latter cells constitute ϳ30% of the cells in the CCD, OMCD, and IMCD and lack the typical Ca 2ϩ transport proteins (Fig.  12A) (171) . Based on differences between the fractional Ca 2ϩ delivery at the last accessible segment in the distal part of the nephron on the surface of the cortex and in the final urine, it was suggested that ϳ3% of the filtered Ca 2ϩ is absorbed by the CCD (385) . Because net transport occurs against the electrochemical gradient in the absence of water transport, the mechanism is thought to be active. In isolated perfused rabbit CCD, Shareghi et al. (344) and Bourdeau and Hellstrom-Stein (55) reported a low Ca 2ϩ permeability and an insignificant net flux that is driven by the membrane potential and not affected by PTH and 1,25-(OH) 2 D 3 . However, other groups demonstrated a significant Ca 2ϩ transport in this segment. Limited Ca 2ϩ transport studies are performed in IMCD tubules. Lechene and co-workers (31) measured Ca 2ϩ transport along the IMCD in rats by the microcatheterization technique. In this study, net Ca 2ϩ reabsorption occurs along the IMCD and the fractional Ca 2ϩ reabsorption is not altered by thyroparathyroidectomy (31) . Ca 2ϩ transport by the IMCD of normal rats was also studied using the in vitro microperfusion technique. Net fluxes of Ca 2ϩ were measured using 45 Ca as a tracer, and Ca 2ϩ influx was independent of Na ϩ transport, was not blocked by verapamil, but was increased by Ca 2ϩ transtubular gradient (244) . In this respect, it is interesting to discuss a recent study that addresses the localization of TRPV6 in the mouse nephron. TRPV6 expression was also detected in OMCD and IMCD and displayed a distinct apical localization (279) . However, the absence of supportive Ca 2ϩ transport proteins, as confirmed by the lack of immunopositive staining for calbindins, questioned the involvement of these cells in Ca 2ϩ reabsorption. Second, intercalated cells also expressed TRPV6. The consistent apical localization would imply that TRPV6 has a functional role as apical Ca 2ϩ entry channel. Hypothetically, TRPV6-mediated Ca 2ϩ influx could affect transport processes in these segments, for instance, as part of a hormonal signaling cascade. In particular, vasopressin was shown to induce Ca 2ϩ influx across the apical membrane of collecting duct cells, and alterations in intracellular Ca 2ϩ levels are known to affect Na ϩ reabsorption in these tubules (130, 364, 390) . Taken together, the present data suggest that Ca 2ϩ reabsorption in the collecting duct is primarily located in the CCD that accounts for maximally 3% of the total amount of Ca 2ϩ filtered at the glomerulus.
B. Gastrointestinal Tract
The small intestine is the largest part of the gastrointestinal tract and is composed of the duodenum, jejunum, and ileum. The large intestine starts after the small intestine in the digestive track and consists of cecum, colon, and rectum. The mechanisms of Ca 2ϩ absorption belong to the best studied processes, deficiencies of which cause significant health problems throughout the world. Intestinal Ca 2ϩ absorption is a crucial control system in the regulation of Ca 2ϩ homeostasis, because it facilitates the entry of dietary Ca 2ϩ into the extracellular compartment. Ca 2ϩ is absorbed by two distinct mechanisms including passive (paracellular) and active (transcellular) transport as outlined in sections II and III, and their relative magnitude of importance is set by the dietary Ca 2ϩ content. Active transcellular Ca 2ϩ absorption is located largely in the duodenum and upper jejunum, whereas paracellular Ca 2ϩ absorption occurs throughout the entire length of the intestine (60) . Chyme moves down the intestinal lumen in ϳ3 h, spending only a short time in the duodenum, but over 2 h in the distal part of the small intestine. In the situation that dietary Ca 2ϩ intake is low, transcellular Ca 2ϩ transport accounts for a substantial fraction of the absorbed Ca 2ϩ , and vice versa, when Ca 2ϩ intake is high (58, 59) .
Transcellular Ca 2ϩ absorption can be described in three sequential cellular steps: entry, intracellular diffusion, and extrusion (see sect. III). The Ca 2ϩ -binding protein calbindin-D 9K is responsible for intracellular diffusion of Ca 2ϩ in the enterocyte, and its gastrointestinal expression has been studied in many species. Yamagishi et al. (436) examined the calbindin-D 9K mRNA expression in the gastrointestinal tract of cattle by Northern blot analysis. Studies in several animal models have shown that calbindin-D 9K and PMCA1b are both expressed in patterns that are compatible with roles in Ca 2ϩ absorption, being found in villous cells of the proximal duodenum and gradually decreased distally, demonstrating vitamin D dependence and decreased expression with aging ( Fig. 12B ) (7, 117, 190, 379, 436, 445) . The expression was highest at the most proximal region. In addition, NCX1 is expressed in the basolateral membrane of mammalian enterocytes (164) . In fish enterocytes, NCX1 appears to be the main mechanism by which transcellular fluxes of Ca 2ϩ are extruded from the cells at the basolateral surface (115) . In contrast, in mammalian enterocytes, Ca 2ϩ extrusion is predominantly dependent on PMCA1b activity (398) .
Recent studies addressed the expression of TRPV5 and TRPV6 in the gastrointestinal tract (Fig. 12B) . Ini-tially, Northern blot analysis showed expression of rabbit TRPV5 in duodenum and jejunum, whereas ileum was negative. However, these hybridizations were performed before the identification of the TRPV6 member using a full-length cDNA as a probe that does not discriminate between the two homologous members (178) . Subsequent studies using isoform-specific probes, quantitative PCR analysis, and immunohistochemical analysis determined the expression of both channels in the gut. These studies showed that TRPV6 is at the mRNA level at least three orders of magnitude higher expressed than TRPV5 (301, 387, 392) . However, at the protein and functional level, it is not clear whether TRPV5 plays a significant role in the intestine, but in line with the observed quantitative mRNA data, a predominant role of TRPV6 is expected in the intestine. Initial characterization of TRPV5 knockout mice that exhibit Ca 2ϩ hyperabsorption, probably mediated by the increased TRPV6 and calbindin-D 9K expression levels, is in agreement with this notion (see sect. VII) (180) . Additional immunohistochemical and functional studies are needed to address a possible role of TRPV5 in the small intestine. In the intestine, TRPV6 expression was found in duodenum, jejunum, and cecum where it colocalizes with calbindin-D 9K and PMCA1b (Fig. 12B) (181, 304, 305) . A comparable study by Hediger and co-workers (305) demonstrated expression of TRPV6 throughout the entire digestive tract from esophagus to colon. For unknown reasons, Flockerzi and co-workers (430) failed to detect TRPV6 (CaT-L) expression in the small intestine and colon.
Recently, TRPV6 and TRPV5 mRNA levels were quantified in mouse by quantitative PCR analysis and normalized for cDNA input. This study demonstrated that TRPV6 mRNA in order of decreasing expression is present in duodenum, cecum Ͼ colon ϾϾ ileum. Likewise, TRPV5 was expressed in kidney ϾϾϾ duodenum, cecum, whereas ileum and colon were negative (279) . Variation in TRPV5 and TRPV6 expression patterns found in different studies in intestine, esophagus, ileum, and colon might be caused by the low abundance of either TRPV5 or TRPV6 in these tissues or differences between species resulting in failure of detection. Immunocytochemical techniques have been used to examine the distribution of TRPV6, TRPV5, calbindin-D 9K , and PMCA1b protein in enterocytes (171). TRPV6 and TRPV5 were localized along the brush-border membrane, whereas calbindin-D 9K and PMCA1b were expressed cytosolic and at the basolateral membrane, respectively (394, 447) . However, at the mRNA level, TRPV6 is 100 times more abundant in the intestine compared with TRPV5. Detailed immunohistochemical studies by Zhuang et al. (447) indicated expression of TRPV6 on the brush-border apical surface of intestinal villi in the entire small intestine and colon. Taken together, these findings are consistent with the postulated role of the epithelial Ca 2ϩ channel TRPV6 as the major transcellular mediator of Ca 2ϩ uptake from the intestinal lumen.
Stomach
A contribution of the stomach in Ca 2ϩ absorption from the gastrointestinal tract has been postulated from in vivo and in vitro studies in different ruminant species, although this organ is not generally considered to play a major role (339) . Unidirectional flux rates of Ca 2ϩ across rumen wall epithelia of sheep were measured in vitro by applying the Ussing-chamber technique in the absence of electrochemical gradients. Under these conditions, significant unidirectional Ca 2ϩ flux rates suggest the presence of active mechanisms for Ca 2ϩ transport (339) . Interestingly, quantitative PCR analyses demonstrated a significant expression of TRPV6 in the stomach, whereas a lower expression of TRPV5 was observed (181, 279) . These data were confirmed at the protein level in which strong labeling of TRPV6 was observed. TRPV6 expression was predominantly expressed in the upper segments of the gastric glands compared with the lower fragments (447) . In this study, it was suggested that TRPV6 plays a role in these mucus-secreting cells in maintaining the intracellular Ca 2ϩ balance after mucus secretion to refill the depleted cellular Ca 2ϩ stores (444, 447) . Functional studies showed that the voltage-operated Ca 2ϩ channel blocker verapamil had no significant effect on Ca 2ϩ transport in rumen that is in line with the insensitivity of the epithelial Ca 2ϩ channels for this inhibitor (178, 303, 339) . In this study a Ca 2ϩ /H ϩ exchange mechanism in the apical membrane of rumen epithelial cells was postulated that does not seem to be under the control of 1,25-(OH) 2 D 3 . Because vanadate did not affect Ca 2ϩ absorption, basolateral Ca 2ϩ extrusion occurs independently from the Ca 2ϩ pump activity and may be accomplished via Na ϩ / Ca 2ϩ exchange (339) . Future studies using isolated mucus-secreting cells from TRPV6 and TRPV5 knockout mice should address the physiological role of these channels in more detail.
C. Others
Placenta
During pregnancy Ca 2ϩ absorption in the placenta is solely responsible for the nutrient supply to the developing fetus. The Ca 2ϩ needs of the fetus increase progressively throughout the pregnancy. Ca 2ϩ is actively transported across the placenta from the maternal to the fetal circulation in late gestation to meet the requirements of the rapidly mineralizing skeleton and to maintain an extracellular level of Ca 2ϩ that is physiologically appropriate for the development of fetal tissues (27- (28, 29) . With the use of animal models, it was demonstrated that the placental expression of calbindin-D 9K increases more than 100-fold over the last 7 days of gestation, whereas the expression of the Ca 2ϩ -ATPase increases twofold over the same interval (146) . Interestingly, initial Northern blot analysis indicated that TRPV5 and TRPV6 are both expressed in placenta (178, 304) . Quantitative PCR analysis in human placenta revealed a robust mRNA expression of TRPV6, whereas TRPV5 was expressed at a very low level (301). Lafond and co-workers (260) demonstrated the expression of TRPV5 and TRPV6 by RT-PCR in cytotrophoblasts freshly isolated from human term placenta. Again, a higher mRNA expression of TRPV6 compared with TRPV5 was measured. This study indicated that the pattern of TRPV6 and TRPV5 expression correlates with the Ca 2ϩ uptake potential along the human trophoblasts isolated from term placenta. These studies provided evidence for a role of the epithelial Ca 2ϩ channels in basal Ca 2ϩ influx during active Ca 2ϩ transport by the syncytiotrophoblast.
Bone
Bone, the major Ca 2ϩ store of the body, is an important tissue involved in Ca 2ϩ homeostasis. Ca 2ϩ removal from and redistribution in bone is mediated by specific bone cells, namely, osteoblasts and osteoclasts. The translocation of Ca 2ϩ from the extracellular fluid compartment into the mineralizing matrix is not well understood at the molecular level. Knowledge on how bone directly contributes to serum Ca 2ϩ homeostasis is virtually absent. It can be via bone resorption and formation, but these processes are relatively slow for rapid responses to changes in serum Ca 2ϩ . To understand Ca 2ϩ movement in bone and Ca 2ϩ homeostasis, it is crucial to identify and characterize the Ca 2ϩ transport processes in bone. The osteoclast is a cell unique in its ability to resorb bone and becomes exposed to high Ca 2ϩ concentrations in the millimolar range (42) . It is generally accepted that, during resorption, osteoclasts can sense changes in their ambient Ca 2ϩ concentration. An increased ambient Ca 2ϩ concentration triggers a sharp cytosolic Ca 2ϩ increase through both Ca 2ϩ release and Ca 2ϩ influx. The boneforming osteoblasts form a layer that later calcifies. Several reports have described calbindin-D 9K expression in rat and human osteoblast-like cells (17, 104, 420) . In these studies, immunoreactive calbindin-D 9K was localized in the cytoplasm of osteoblasts. Moreover, calbindin-D 28K was expressed at low levels in several osteoblastic cell lines and at high levels in primary cultures of murine osteoblastic cells. Its localization in osteoblasts involved in bone formation and in their cell processes suggests a role in Ca 2ϩ transport from these cells toward the sites of active bone mineralization. Interestingly, TRPV5 and TRPV6 mRNA have been detected in bone cells isolated from mouse femurs (279) . To date, information on expression and localization of these proteins in bone cells is limited, and their functions in matrix mineralization are unclear.
Exocrine tissues
Exocrine tissues such as pancreas, testis, prostate, mammary gland, sweat gland, and salivary gland are not primarily implicated in transepithelial Ca 2ϩ transport. Interestingly, several studies have demonstrated expression of Ca 2ϩ -transporting proteins in these exocrine tissues by Northern blot, PCR analysis, or immunohistochemistry. In pancreas, TRPV5 was observed in secretory granules of the ␤-cells where it colocalized with calbindin-D 28K and insulin (194) . This study suggested a role for TRPV5 in insulin secretion, although such a role could not be confirmed in studies on the pancreas of Zucker diabetic fatty (ZDF) rats, an animal model for type 2 diabetes mellitus. Interestingly, insulin secretion is impaired in vitamin Ddeficient rats (202) but restored by vitamin D treatment (193) . Sooy et al. (362) suggested that calbindin-D 28K could control the rate of insulin release via regulation of the intracellular Ca 2ϩ concentration. Like in kidney, in pancreatic ␤-cell NCX, PTH-related peptide (PTHrP), calbindin-D 28K and receptors for 1,25-(OH) 2 D 3 have been detected (76, 97, 198, 396) . In contrast to TRPV5, TRPV6 mRNA is found in the exocrine acinar cell of the pancreas, but not in pancreatic duct and ␤-cells (430, 447) . In the human pancreas, acinar cells showed a granular and apical membrane staining of TRPV6 (447) . In addition, a weak signal was found along the basolateral membrane that could be involved in Ca 2ϩ entry from the circulation. Ca 2ϩ extrusion in the acinar pancreatic cell has been studied in great detail. With the use of confocal microscopy and Ca 2ϩ -sensitive fluorescent probes, it was shown that the secretory pole of the acinar cell is the major Ca 2ϩ extrusion site following agonist stimulation (25, 26 (111, 176, 265, 279, 305, 306, 430, 447) . Although the exact function in this organ remains to be elucidated, previous reports have suggested that TRPV6 expression correlates with prostate carcinoma tumor grade (111, 306) . The first indication of TRPV6 as tumor progression marker came from expression studies in human prostate cancer cell lines (306) . Expression of TRPV6 was elevated in prostate cancer samples compared with benign prostatic hyperplasia specimens and positively correlated with Gleason grade in prostate cancer. TRPV6 mRNA was downregulated by androgen and induced by a specific androgen receptor antagonist in LNCaP cells, suggesting that the expression of this channel is negatively regulated by androgen. Flockerzi and co-workers (430) identified a transcript from rat duodenum, named CaT-L, which was expressed in locally advanced prostate cancer and metastatic and androgen-insensitive prostatic lesions, but was undetectable in healthy prostate tissue (430) . Detailed characterization of CaT-L demonstrated that this gene is identical to TRPV6. Recently, it was reported that CaT-L or TRPV6 is not expressed in benign prostate tissues including benign prostate hyperplasia, but is upregulated in prostate cancer. Other reports indicated that TRPV6 mRNA (279) and protein (447) are also expressed in normal prostate tissue. In prostatectomy specimens from 97 clinically organ-confined tumors, TRPV6 expression correlated significantly with the Gleason score, pathological stage, and extraprostatic extension (111) . Together these findings indicate that TRPV6 expression is associated with prostate cancer progression and, therefore, represents a prognostic marker and a promising target for new therapeutic strategies to treat advanced prostate cancer.
Interestingly, several exocrine glands including sweat, salivary, and mammary glands do express one or both of the epithelial Ca 2ϩ channels. Freeman and coworkers (447) demonstrated that TRPV6 is localized in the mammary gland along the luminal membrane of the epithelial cells in contrast to localization in the sweat gland where the channel was detected on both the luminal and basolateral membrane surfaces. Differences in the localization of TRPV6 may reflect diverse physiological functions in these exocrine glands. To date, TRPV5 expression in these exocrine glands remains to be established. In addition, functional studies are needed to examine the physiological function of the epithelial Ca 2ϩ channels in these tissues.
VI. REGULATION OF EPITHELIAL CALCIUM TRANSPORT
A. Regulation by 1,25-(OH) 2 D 3
It is commonly accepted that vitamin D 3 is one of the main hormones controlling Ca 2ϩ balance (322) . There are two sources of vitamin D 3 in the body. It is either ingested from the diet or synthesized in the skin from its precursor 7-dehydrocholesterol in the presence of sunlight (271) . Vitamin D 3 itself is physiologically inactive. It will undergo an activation process, involving 25-hydroxylation in the liver followed by 1␣-hydroxylation in the kidney to synthesize the biologically active 1,25-(OH) 2 D 3 . The latter reaction step occurs in mitochondria of the renal proximal tubule (116 (38, 175) . The effects underlying at least part of these processes are mediated by the interaction of 1,25-(OH) 2 D 3 with the nuclear VDR in a ligand-dependent manner (159) . This genomic mechanism of action is similar to that of other steroid hormones and is mediated by stereospecific interaction of 1,25-(OH) 2 D 3 with the VDR which heterodimerizes with the retinoid X receptor (RXR) (211) . After interaction with the vitamin D response element (VDRE) in the promoter of target genes, transcription proceeds through the interaction of VDR with coactivators and with the transcription machinery. Importantly, VDR is expressed in epithelia that play a role in Ca 2ϩ (re)absorption. The functional significance of target proteins as well as the functional significance of proteins involved in the transport and metabolism of vitamin D is also of major importance. In general, transcellular Ca 2ϩ transport in the small intestine and the distal part of the nephron is facilitated by the Ca 2ϩ transport proteins, namely, TRPV5, TRPV6, the calbindins, NCX1 and PMCA1b, and stimulated by 1,25-(OH) 2 D 3 primarily via a genomic action. The contribution of each individual trans-porter to the overall stimulatory action of 1,25-(OH) 2 D 3 has been addressed in several studies as described in the following section.
Calbindins
Early studies demonstrated that 1,25-(OH) 2 
Basolateral extrusion mechanisms
The effect of 1,25-(OH) 2 D 3 on the basolateral extrusion systems, NCX1 and PMCA1b, is less clear and remains controversial. Although NCX1 plays a dominant role in the extrusion process in renal cells (121, 184, 243, 427) , many studies failed to establish a direct regulation by vitamin D. Exposure of 1,25-(OH) 2 D 3 to primary cultures of rabbit DCT and CNT did not noticeably alter NCX1 expression (391) . However, repletion studies with vitamin D-deficient animal models consistently demonstrated a vitamin D-dependent regulation of renal NCX1 and duodenal PMCA1b (see sect. VI). Importantly, these studies in mice indicated that renal PMCA1b expression and intestinal NCX1 expression were not significantly regulated by vitamin D. PMCA1b is the only isoform predominantly expressed in small intestine and kidney (8, 391) . In kidney, it has been shown experimentally that during variable circumstances the extrusion capacity of PMCA1b is more than adequate, suggesting that the Ca 2ϩ exit step is not necessarily a prime target for regulation by 1,25-(OH) 2 D 3 (391) . This could perhaps explain the difficulty to observe a consistent stimulatory effect of 1,25-(OH) 2 D 3 on renal PMCA1b (169, 392 (8, 9, 387, 392) . Furthermore, 1,25-(OH) 2 D 3 enhanced PMCA1b mRNA stability and activity (147, 148) . However, other reports in which primary cultures of renal cells and animal models were used failed to show significant regulation of renal PMCA1b expression level by 1,25-(OH) 2 D 3 (391, 392) . Conversely, run-off reporter gene assays using 1.7 kb of the human PMCA1 promoter expressed in distal tubular cell lines demonstrated mRNA downregulation by 1,25-(OH) 2 D 3 (149) . Taken together, a consistent stimulatory effect of 1,25-(OH) 2 D 3 on NCX1, but not on PMCA1b, in the kidney has been established. In the small intestine, however, PMCA1b is the vitamin D-regulated extrusion system.
Epithelial Ca 2ϩ channels
Recent studies consistently indicated that the expression of TRPV5 and TRPV6 is tightly controlled by 1,25-(OH) 2 D 3 (51, 61, 112-114, 169, 174, 279, 359, 387, 392, 435) . The first evidence for this vitamin D sensitivity was obtained in in vivo studies in which vitamin D 3 -depleted rats were repleted (174) . This was accompanied by normalization of the plasma Ca 2ϩ concentration and an increase in the amount of TRPV5 mRNA and protein expression in the kidney. As a different approach to elicit vitamin D genomic responses, a single dose of 1,25-(OH) 2 D 3 was administered to mice (392) . Quantitative PCR data demonstrated an upregulation of TRPV5 in kidney (3-fold) and TRPV6 in duodenum (6-fold). Recently, Nijenhuis et al. (279) addressed the localization and 1,25-(OH) 2 D 3 -dependent regulation of TRPV6 in the kidney. Intraperitoneal injection of 100 ng 1,25-(OH) 2 D 3 in mice resulted in a increase in TRPV6 mRNA (2-fold) and protein (3-fold) expression in the kidney. Although renal TRPV6 expression was upregulated by 1,25-(OH) 2 D 3 , the effect of this hormone on TRPV5 expression was more impressive. Analysis of putative promoter regions of human and murine TRPV5/6 genes revealed potential vitamin D response elements in line with the previously observed functional data (174, 279) . Song et al. (359) also examined the expression of TRPV5 and TRPV6 mRNA in duodenum and kidney of mice. Following a single dose of 1,25-(OH) 2 D 3 , induction of duodenal TRPV6 mRNA occurred within 3-6 h and preceded the induction of intestinal Ca 2ϩ absorption. In addition, this study described that the intestinal TRPV6 mRNA level increased 30-fold at weaning, coincident with the induction of calbindin-D 9K expression. In contrast, renal TRPV6 and TRPV5 mRNA expression was equal until weaning when TRPV5 mRNA is induced and TRPV6 mRNA levels drop 70% (359) . The observed vita-min D-dependent regulation of TRPV5 and TRPV6 was subsequently extensively studied using many different cell lines and animal (knockout) models as discussed in the next paragraph.
Vitamin D-dependent regulation of Ca 2ϩ transport in animal models
Powerful tools to investigate the vitamin D dependency of target proteins are knockout mice. Within the past few years a wealth of new information has been obtained from studies using knockout and transgenic mice. Several genetically modified mouse models including VDR (392, 440) and thus controlling feedback inhibition of TRPV5/6 channel activity (404) .
Analogous observations were made from experiments performed with VDR knockout mice (392, 423) . In these hypocalcemic mice, urinary Ca 2ϩ excretion is inappropriately high, suggesting renal Ca 2ϩ wasting due to disturbed Ca 2ϩ reabsorption. It has been demonstrated in this mouse model that duodenal TRPV6 levels are dramatically and consistently downregulated (392, 423) . Intriguingly, the observed expression pattern indicated that, among the candidate Ca 2ϩ -transporting genes, mainly TRPV6 is severely impaired in VDR-knockout mice.
In addition, the correlation between vitamin D and the expression level of the Ca 2ϩ transport proteins has been addressed in several cell models. Wood and coworkers (113, 435) (20) could not confirm the generally observed vitamin D-dependent sensitivity of TRPV6 in duodenal biopsies from 20 normal volunteers. However, there was a 10-fold variation between the lowest and the highest level of TRPV6 expression. In addition, the subjects used were a mixed population of men and women of age 25-71 years, which made it hard to disclose a relationship between TRPV6 expression and vitamin D metabolites. Likewise, cell lines and primary cultures have been established from the distal part of the nephron including DCT and CNT (38, 91, 391) . 
B. Regulation by PTH
The parathyroid glands play a key role in maintaining the extracellular Ca 2ϩ concentration through their capacity to sense even minute changes in the level of blood Ca 2ϩ from its normal level. The Ca 2ϩ -sensing receptor (CaSR) is the mechanism through which the parathyroid chief cells sense variations in the Ca 2ϩ concentration and release PTH. In response to low blood Ca 2ϩ levels, PTH is secreted into the circulation and then acts primarily on kidney and bone, where it activates the PTH/PTHrP receptor. This receptor directly enhances the tubular Ca 2ϩ reabsorption, and it stimulates the activity of 1␣-OHase and, thereby, increases the 1,25-(OH) 2 D 3 -dependent absorption of Ca 2ϩ from the intestine. Several groups localized PTH/PTHrP receptor mRNA in rat kidney to glomerular podocytes, PCT, PST, cortical thick ascending limb, and DCT, but the receptor was not detected in the thin limb of Henle's loop or in CD (231, 437) . PTH stimulates active Ca 2ϩ reabsorption in the distal part of the nephron (154) . As outlined in section III, Bindels et al. (38) and Gesek and Friedman (124) have used immunodissected cell lines from rabbit DCT and CNT and mouse DCT, respectively, to investigate PTH-stimulated Ca 2ϩ transport. These studies demonstrated equivocally that PTH increases transepithelial Ca 2ϩ transport via a dual signaling mechanism involving PKA-and PKC-dependent processes (124, 170) . Various mechanisms of PTH action have been postulated including membrane insertion of apical Ca 2ϩ channels (12), opening of basolateral chloride channels resulting in cellular hyperpolarization (127) , and modulation of PMCA activity (383 . Their results demonstrated that PTH activates dihydropyridine-sensitive channels responsible for Ca 2ϩ entry. Once inserted or activated, these dihydropyridine-sensitive channels could mediate Ca 2ϩ entry into these Ca 2ϩ -transporting epithelial cells (12) . This finding is in contrast to the channel characteristics of TRPV5 that is dihydropyridine insensitive (178) . It is well possible that these dihydropyridine-sensitive Ca 2ϩ channels play a role in signal transduction processes to maintain the cellular Ca 2ϩ homeostasis. Recently, it was reported that parathyroidectomy in rats resulted in decreased serum PTH levels and hypocalcemia, which was accompanied by decreased levels of TRPV5, calbindin-D 28K , and NCX1 (388) . Supplementation with PTH restored serum Ca 2ϩ concentrations and abundance of these Ca 2ϩ transporters in kidney. These data suggest that PTH affects renal Ca 2ϩ handling through the regulation of the expression of the active renal Ca 2ϩ transport proteins, including the epithelial Ca 2ϩ channel TRPV5. Furthermore, it was demonstrated that PTH stimulates the PMCA activity by increasing the affinity for Ca 2ϩ in the distal tubule, which is in contrast to 1,25-(OH) 2 D 3 that did not directly affect the basolateral membrane PMCA activity (383) .
Immunohistochemical analysis of rat duodenal sections showed localization of the PTH/PTHrP receptor in epithelial cells along the villus with intense staining of brush-border and basolateral membranes and cytoplasm (135) . Interestingly, the receptor was absent in goblet cells. Direct effects of PTH have been reported on Ca 2ϩ uptake by isolated rat duodenal cell preparations enriched in enterocytes. The first indication of a direct effect of PTH on the intestine was accomplished by perfusion experiments of isolated duodenal loops with PTH that increased Ca 2ϩ transport (272, 273) . These findings were confirmed by Picotto et al. (309) who demonstrated that PTH significantly stimulates enterocyte Ca 2ϩ influx. This Ca 2ϩ influx was blocked by the Ca 2ϩ channel antagonists verapamil and nitrendipine.
In bone, PTH can induce a rapid release of Ca 2ϩ from the bone matrix, but it also mediates long-term changes in Ca 2ϩ metabolism by acting directly on the bone-forming osteoblasts and indirectly on bone-resorbing osteoclasts by increasing their number and activity. However, molecular mechanisms of PTH action in mediating Ca 2ϩ transport in bone and intestine remain poorly understood.
C. Regulation by Calcitonin
Calcitonin, a 32-amino acid peptide hormone produced primarily by the thyroid, and its receptor are well known for their ability to regulate osteoclast-mediated bone resorption (186) . Calcitonin has been suggested to be a renal Ca 2ϩ -conserving hormone and may share similar signaling mechanisms with PTH. Previously, this peptide was infused into groups of acutely thyroparathyroidectomized rats that had been treated with calcitonin for 12 days resulting in a marked inhibitory effect on renal Ca 2ϩ excretion (67). The hypocalcemic and hypophosphatemic calcitonin is secreted by mammalian thyroid parafollicular cells. It has been reported that calcitonin increases Ca 2ϩ reabsorption in mouse DCT cells, but the molecular mechanism is not known yet. It was postulated that calcitonin increases Cl Ϫ conductance in DCT cells, resulting in membrane hyperpolarization and activation of Ca 2ϩ entry through Ca 2ϩ channels (139) . Interestingly, renal 1␣-OHase gene expression is strictly upregulated at the transcriptional level through its gene promoter by PTH and calcitonin, whereas 1,25-(OH) 2 D 3 itself has a negative effect on gene expression (205 efflux from isolated cat tibiae that underlies its widespread clinical use for the treatment of bone disorders, including Paget's disease, osteoporosis, and hypercalcemia of malignancy.
D. Regulation by Stanniocalcin
Stanniocalcin is another hypocalcemic hormone that is originally identified in fish (414) . In these animals stanniocalcin exerts its antihypercalcemic effect by regulating Ca 2ϩ and phosphate transporters in the gills, intestine, and kidney (136a). Interestingly, this hormone has also been recently identified in humans (415) . In mammals, stanniocalcin is expressed in multiple organs including Ca 2ϩ -transporting epithelia like intestine, colon, kidney, and placenta (70, 71). It is released by specialized organs, the corpuscles of Stannius that are located adjacent to the kidney and scattered throughout the kidney (415). Immunoreactivity for stanniocalcin was detected in the limb of Henle, macular densa cells, DCT, and CCD (297) . Stanniocalcin acts locally in kidney and gut to modulate Ca 2ϩ and phosphate excretion, and its overexpression in mice results in high serum phosphate, dwarfism, and increased metabolic rate (109, 401) . The main function of stanniocalcin, similar to that of calcitonin, appears to be the prevention of hypercalcemia. Importantly, stanniocalcin was upregulated by 1,25-(OH) 2 D 3 treatment (188, 297) . Nevertheless, the true physiological role for stanniocalcin in mammals is less clear, and future studies are needed to establish the functional importance of this hormone.
E. Regulation by Estrogens
Estrogen deficiency results in a negative Ca 2ϩ balance and bone loss in postmenopausal women (289, 441, 442) . Estrogen deficiency after menopause results in bone loss, which is associated with a rise in plasma and urinary Ca 2ϩ (442) . It has been generally described that the rise in plasma and urine Ca 2ϩ are secondary to an increase in bone resorption. However, some studies have shown that the rise in urinary Ca 2ϩ at menopause is not due to an increase in filtered load, suggesting that estrogen also has an effect on renal Ca 2ϩ handling (1) . In addition to bone, the intestine and kidney are also potential sites for estrogen action and involved in Ca 2ϩ handling and regulation. There is increasing evidence that estrogen exerts a physiological role in the regulation of renal and intestinal Ca 2ϩ (re)absorption. In vivo studies showed that estrogen deficiency is associated with increased renal Ca 2ϩ loss, which can be corrected by estrogen replacement therapy (290, 315) . Furthermore, estrogen receptors also reside in proximal and distal tubules of the kidney and in duodenum and colon. However, the underlying mechanism by which estrogen may act on Ca 2ϩ (re)absorption is still poorly understood. In addition, it has not been conclusively established whether there is a direct effect of estrogen on Ca 2ϩ transport or indirectly mediated by an effect on vitamin D metabolism. It was demonstrated that estrogen upregulates the expression of TRPV5 in kidney in a 1,25-(OH) 2 D 3 -independent manner (386) . In ovariectomized 1␣-OHase knockout mice, 17␤-estradiol replacement therapy resulted in upregulation of renal TRPV5, but not the other Ca 2ϩ transporters, mRNA, and protein levels, leading to normalization of plasma Ca 2ϩ levels (386). Thus renal TRPV5 expression is, independent of vitamin D, transcriptionally controlled by estrogen. By upregulating TRPV5 expression, estrogen could be positively involved in Ca 2ϩ reabsorption. Recent findings suggest that also TRPV6 expression is regulated by estrogen, as duodenal expression of TRPV6 mRNA of 1␣-OHase knockout mice and ovariectomized rats is upregulated after 17␤-estradiol administration (387) . Van Cromphaut et al. (393) reported that renal TRPV5 and duodenal TRPV6 expression are reduced in estrogen receptor ␣ (ER␣) knockout mice and upregulated by estrogen treatment. In this study, TRPV6 expression was enhanced in both pregnant VDR knockout mice and wild-type littermates. Furthermore, in lactating mice, renal TRPV5 mRNA and duodenal TRPV6 expression levels increased 2 and 13 times, respectively. It is clear that the expression of both epithelial Ca 2ϩ channels is influenced by the estrogen status. Estrogens, hormonal changes during pregnancy, and lactation have distinct, vitamin D-independent effects at the genomic level on active duodenal Ca 2ϩ absorption mechanisms, mainly through a major upregulation of TRPV6. The estrogen effects seem to be mediated solely by ER␣. Nevertheless, it remains to be clarified whether these changes have functional implications on Ca 2ϩ (re)absorption. These data confirm that estrogens and vitamin D are independent potent regulators of the expression of TRPV6, which is involved in active intestinal Ca 2ϩ absorption. Together, these data indicate that the function of estrogen in maintenance of the Ca 2ϩ balance might be at least in part fulfilled by regulation of TRPV5 and TRPV6 levels, thereby controlling (re)absorption of the amount of Ca 2ϩ that is needed for bone calcification.
The mechanism of estrogen-controlled upregulation of epithelial Ca 2ϩ channel mRNA remains to be elucidated. Interestingly, Weber et al. (423) recently described an estrogen-responsive element in the promoter sequence of the mouse TRPV6 gene, which was absent in the mouse TRPV5 gene. Alternatively, transcriptional activation by the estrogen-liganded estrogen receptor can be mediated through other elements including activator protein 1 (AP-1) binding sites and GC-rich stimulatory protein (Sp1) binding sites (224, 334) . Importantly, the human TRPV5 promoter contains several of these AP-1 and Sp1 sites (174) . In the 5Ј-upstream region of the translational initiation site in the mouse TRPV5 gene, several of these AP-1 and Sp1 binding sites can be found that could be involved in the positive effect observed on TRPV5 mRNA expression by 17␤-estradiol treatment. Detailed promoter analysis is necessary to identify the regulatory sites involved in this estrogen-mediated regulation of TRPV5 and TRPV6.
F. Regulation by Thyroid Hormone
There is ample evidence that thyroid dysfunction is associated with disturbances of Ca 2ϩ and phosphate homeostasis (81-83, 222, 223, 263) . Hypercalcemia is frequently observed in humans with thyrotoxicosis, and similar observations were made in animals (103, 160, 223, 333) . It is interesting that long-term hyperthyroid state is associated with Ca 2ϩ malabsorption and increased bone resorption. Several effects of thyroid hormone on the kidney, intestine, and bone resemble those of 1,25-(OH) 2 D 3 . Actions at the cellular level constituting their function as Ca 2ϩ -regulating hormones have not been addressed until recently. Kumar and Prasad (223) demonstrated that Ca 2ϩ uptake into brush-border membrane vesicles and Ca 2ϩ efflux from the basolateral membrane of enterocytes was significantly increased in hyperthyroid rats and decreased in hypothyroid animals. Comparable observations were made in the kidney by these investigators (222) . It was postulated that thyroid hormone increases the affinity of TRPV6 for Ca 2ϩ in the brush-border membrane of the enterocyte. However, experiments to confirm this hypothesis remain to be performed.
G. Regulation by Dietary Ca
2؉
Dietary Ca 2ϩ is one nutrient that has been the focus of multiple studies in an effort to discover its preventive actions. It has been implicated in the reduction of risk in osteoporosis, whereas a low-Ca 2ϩ diet avoids kidney stone formation. Obesity, hypertension, and even cancer are less well-known areas in which increasing dietary Ca 2ϩ has a positive outcome (232) . A significant link between Ca 2ϩ intake and bone mass has been reported. Although recommended daily allowance of calcium is 600 mg/day for adults, ϳ850 mg/day or more is recommended later in life.
The power of Ca 2ϩ supplementation is best illustrated by the use of VDR and 1␣-hydroxylase knockout models. The bone phenotype of VDR-ablated mice can be completely rescued by feeding the animals a high-Ca 2ϩ , high-phosphorus, high-lactose diet. In addition, the PDDR phenotype of mice deficient for the 1␣-OHase gene has been rescued by feeding them with the high-Ca 2ϩ diet. The rescue regimen consisted of feeding a diet containing 2% (wt/wt) Ca 2ϩ from 3 wk of age until death at 8.5 wk of age. Serum analysis revealed that the rescue diet corrected the hypocalcemia and secondary hyperparathyroidism (87, 168, 169).
Subsequently, the expression level of the Ca 2ϩ transport proteins was studied in the knockout mice models described above. Several aforementioned studies provided evidence that the Ca 2ϩ transport proteins, including TRPV5 and TRPV6 channels, are regulated by 1,25-(OH) 2 D 3 . It is, however, difficult to distinguish the effects of hypocalcemia from those of vitamin D deficiency. Therefore, studies were performed in VDR and 1␣-OHase knockout mice fed a normal and high-Ca 2ϩ rescue diet (169, 392 
H. Regulation by the Ca 2؉ -Sensing Receptor
The CaSR plays a pivotal role in the regulation of Ca 2ϩ homeostasis by sensing subtle changes in circulating Ca 2ϩ concentration (185) . In the parathyroid gland, the CaSR represents the molecular mechanism by which parathyroid cells detect changes in blood ionized Ca 2ϩ concentration, modulate PTH secretion accordingly, and thus maintain serum Ca 2ϩ levels within a narrow physiological range. Interestingly, in the kidney, the CaSR regulates renal Ca 2ϩ excretion and influences the transepithelial movement of water and other electrolytes. The CaSR is expressed at numerous sites along the nephron including the apical membrane of the PT, the basolateral membrane of the medullary and cortical TAL and DCT, in some cells of CCD, and at the apical membrane of the IMCD. Thus CaSR can apparently be trafficked either to the apical or to the basolateral membrane depending on the tubule cell type. The receptor is located in the epithelial cells of the PT, where it is located in close proximity to the numerous apical transporters of various nutrients and electrolytes that reside within this portion of the nephron (329) . There is evidence that the CaSR in the PT antagonizes or limits the effects of PTH as stimulator of 1,25-(OH) 2 D 3 production and phosphate excretion (11 (330) . Furthermore, it has been demonstrated that a high luminal Ca 2ϩ concentration activates the CaSR receptor in the apical membrane of the IMCD. As a consequence, the vasopressin-elicited water permeability is blunted by a PKC-mediated aquaporin-2 retrieval mechanism to reduce water reabsorption and prevent a further rise in urinary Ca 2ϩ concentration (335) . These data are the first analyses of hypercalcemia-induced alterations in arginine vasopressin-regulated water permeability and membrane transporters in IMCD. It is hypothesized that alterations in IMCD transport occur during hypercalcemia, allowing the body to dispose of excess Ca 2ϩ without forming Ca 2ϩ -containing renal stones. CaSR forms a unique molecular target for drugs that can directly alter the activity of the receptor, thereby manipulating the extracellular Ca 2ϩ balance. Several calcimimetic compounds, like NPS R-467, have been described that activate CaSRs on parathyroid cells and suppresses serum levels of PTH and Ca 2ϩ . However, the involvement of intestinal and renal Ca 2ϩ (re)absorption in the NPS R-467-induced hypocalcaemia is not clear. A recent study by van Abel et al. (388) investigated the effect of NPS R-467 on the expression of intestinal and renal Ca 2ϩ transport proteins, including the epithelial Ca 2ϩ channels TRPV5 and TRPV6. To this end, mice were infused with NPS R-467 via osmotic minipumps for 7 days. Treatment with NPS R-467 reduced serum PTH levels in a dose-dependent manner, which was accompanied by a significant decrease in serum Ca 2ϩ concentration. Quantitative PCR and biochemical analysis of duodenal and renal samples demonstrated an overall downregulation of mRNA expression levels and proteins involved in active transcellular Ca 2ϩ (re)absorption. The effects of the treatment with NPS R-467 on the expression of Ca 2ϩ transporters could involve a direct action of CaSRs in kidney and/or intestine; however, previous studies have also indicated that the acute hypocalcemic response to calcimimetic compounds results from the inhibition of PTH secretion (388).
I. Regulation by Associated Proteins
To date, little information is available concerning the molecular players responsible for regulating the activity of TRPV5 and TRPV6. A number of regulatory proteins have recently been described that modify the biophysical, pharmacological, and expression properties of ion channels and transporters by direct interactions (233) . These newly identified associated proteins have facilitated the elucidation of important molecular pathways modulating transport activity. Until now three regulatory proteins, i.e., calmodulin, S100A10-annexin 2, and 80K-H, have been described that associate with TRPV5 and/or TRPV6 (145, 276, 394 ).
Calmodulin
CaM was identified as a TRPV6-interacting member and is a ubiquitous cytosolic protein known to regulate the activity of different ion channels, Ca 2ϩ pumps, and other proteins in a Ca 2ϩ -dependent manner (276) . CaM consists of four Ca 2ϩ -binding EF-hand structures, which are localized in the amino and carboxy terminus. Ca 2ϩ binding to CaM is highly cooperative with Ca 2ϩ binding first to the carboxy-terminal EF-hands, which have the highest affinity for Ca 2ϩ , followed by Ca 2ϩ binding to lower affinity sites located in the amino terminus (418) . At rest, when Ca 2ϩ concentrations are low, Ca 2ϩ entry through voltage-gated Ca 2ϩ channels, cyclic nucleotidegated channels, and NMDA receptors is enabled. Upon Ca 2ϩ influx, activated Ca 2ϩ -CaM inactivates the abovementioned influx pathways as well as TRPL-mediated currents in Drosophila photoreceptors (341) . In addition, other members of the TRP family are possibly regulated by CaM. CaM binding to TRPV1 was restricted to a 35-amino acid segment in the carboxy terminus, and deletion of this CaM binding segment prevented TRPV1 desensitization (293) . Members of the TRPC family have been shown to bind CaM (52, 225, 439) . CaM acts as a Ca 2ϩ sensor in the Ca 2ϩ -dependent feedback inhibition of TRPC1 as demonstrated using Ca 2ϩ -insensitive CaM mutants (356) . Another study using CaM inhibitors described that TRPC6 is regulated by CaM (52) .
There is a rapid Ca 2ϩ -dependent inactivation of TRPV6 channels that seems to be independent of CaM binding and could be due to a local effect of Ca 2ϩ on the intracellular pore-forming region (276) . This conclusion was based on the observation that the inactivation behavior of TRPV6 was altered in mutants that do not bind CaM. In addition, there was a slower inactivation that was found to be Ca 2ϩ /CaM dependent. Interestingly, binding of Ca 2ϩ /CaM, however, can be prevented by PKC-mediated phosphorylation of a threonine residue within the CaM binding site. Niemeyer et al. (276) concluded that PKC activity thus may act as a switch that can regulate the amount of Ca 2ϩ influx through TRPV6 channels by altering their inactivation behavior. These results suggest a model in which TRPV6-expressing cells can have a substantial Ca 2ϩ influx, where phosphorylation of TRPV6 can act as a positive-feedback system, delaying the inactivation process. The described mechanism of competitive regulation of TRPV6 by PKC and CaM is, however, restricted to human TRPV6, since this particular PKC site in the CaM-binding motif is not conserved in the other species (276) . Recently, the corresponding region in mouse TRPV6 was shown to bind CaM (167) . Detailed analysis of the binding region predicted a caseine kinase motif, but no significant phosphorylation could be detected in this particular domain. The regulation of TRPV6 by CaM was recently confirmed by Lambers et al. (229) . By combination of pull-down assays and coimmunoprecipitations, it was demonstrated that CaM binds to both TRPV5 and TRPV6 in a Ca 2ϩ -dependent fashion. The binding of CaM to mouse TRPV6 was localized to the transmembrane domain and consensus CaMbinding motifs located in the amino [1-5-10 motif, TRPV6-(88O97)] and carboxy termini [1-8-14 motif, TRPV6-(643O656)], suggesting a mechanism of regulation involving multiple interaction sites (229) . Electrophysiological experiments demonstrated that HEK293 cells heterologously expressing TRPV5 or TRPV6 and CaM mutants revealed that TRPV6, but not TRPV5, is negatively regulated by an inactive CaM mutant. This finding is remarkable given the high homology between both channels, similar Ca 2ϩ -dependent regulation of channel activity, and binding of CaM to both channels. Furthermore, the effect of CaM was mediated by the high Ca 2ϩ affinity EF-hand structures 3 and 4 present in the carboxy terminus of CaM (229).
S100A10-annexin 2
Recently, an auxiliary protein of TRPV5 and TRPV6 was identified by screening a mouse kidney cDNA library using the yeast two-hybrid system. A bait was constructed with the cytoplasmic carboxy-terminal region of TRPV5. This study described the identification of the first auxiliary protein for TRPV5 and TRPV6, named S100A10, which specifically associates with the carboxy termini of these epithelial Ca 2ϩ channels (394) . S100A10 is a 97-amino acid protein member of the S100 superfamily that is present in a large number of organisms including vertebrates, insects, nematodes, and plants. S100A10 is predominantly present as a heterotetrameric complex with annexin 2, which has been implicated in numerous biological processes including endocytosis, exocytosis, and membrane-cytoskeleton interactions (136) . Annexin 2 interacts with actin and is postulated to bind to the cytoplasmic face of membrane rafts to stabilize these domains, thereby providing a link to the actin cytoskeleton. Several members of the S100 protein family form heteromeric complexes with annexins: S100A11 with annexin 1 (247), S100A6 with annexin 2 (380), and S100A10 is often found tightly associated with annexin 2 to form a tetrameric complex (326) . Van de Graaf et al. (394) provided the first evidence of a regulatory role for the S100A10-annexin 2 heterotetramer in vitamin D-mediated Ca 2ϩ (re)absorption in general and in particular in TRPV5 and TRPV6 functioning. The association of S100A10 with TRPV5 and TRPV6 was restricted to a short peptide sequence VATTV located in the carboxy termini of these channels. This stretch is conserved among all identified species of TRPV5 and TRPV6 (394) . Interestingly, the TTV sequence in the S100A10 binding motif resembles an internal type I PDZ consensus binding sequence, which is S/TXV (360). However, S100A10 does not contain PDZ domains, indicating that the TRPV5-S100A10 interaction has a different nature. The first threonine of the S100A10 interaction motif was identified as a crucial determinant for binding. Furthermore, the activity of TRPV5 and TRPV6 was abolished when this particular threonine was mutated, demonstrating that this motif is essential for channel function. Malfunctioning of these mutant channels was accompanied by a major disturbance in their subcellular localization, indicating that the S100A10-annexin 2 heterotetramer facilitates the translocation of TRPV5 and TRPV6 channels to the plasma membrane. The importance of annexin 2 in this process was demonstrated by a siRNA-based downregulation of annexin 2 that significantly inhibited the currents through TRPV5 and TRPV6, indicating that annexin 2 in conjunction with S100A10 is crucial for TRPV5 activity. In line with the cortical localization of annexin 2 and its postulated function in organizing certain plasma membrane domains, these findings provided the first functional evidence for a regulatory role of annexin 2 controlling Ca 2ϩ channel trafficking. Interestingly, previous studies indicated that the background K ϩ channel (TASK1) is associated with S100A10 via its carboxy-terminal sequence SSV (142) . The S100A10 interaction promoted the translocation of TASK1 to the plasma membrane producing functional K ϩ channels. This sequence resembles the binding motif in TRPV5 and TRPV6 identified in the present study, suggesting a shared structural S100A10 binding pocket. However, this motif is absent in the tetrodotoxin-insensitive voltagegated Na ϩ channel (Nav1.8), which has been shown to bind S100A10 via its amino terminus and essential for plasma membrane trafficking (296) . Interestingly, in line with the epithelial Ca 2ϩ channels, S100A10 expression was found to be vitamin D sensitive (394) . In addition, annexin 2 expression levels have been shown to increase upon prolonged incubation with 1,25-(OH) 2 D 3 (252) . Coregulation of TRPV5/6, S100A10, and annexin 2 could fulfill the essential control of trafficking of these channels to the plasma membrane. 1,25-(OH) 2 D 3 has been shown to exert its effects by slow and rapid mechanisms. The slower genomic effects are mediated by interaction with the nuclear VDR. Recently, it was reported that annexin 2 serves as a membrane receptor for 1,25-(OH) 2 D 3 and mediates the rapid effect of the hormone on intracellular Ca 2ϩ . It has been demonstrated that 1,25-(OH) 2 D 3 is specifically bound to annexin 2 in the plasma membrane of rat osteoblast-like cells (18, 19 2 (253a) . Taken together, these findings show that the S100A10-annexin 2 complex is a significant component for the trafficking of ion channels to the plasma membrane in general and in particular a major regulator of TRPV5 and TRPV6 function and, therefore, the Ca 2ϩ homeostasis.
80K-H
By the use of cDNA microarrays, Gkika et al. (145) identified 80K-H as a protein involved in the Ca 2ϩ -dependent control of TRPV5 (145) . 80K-H was initially identified as a PKC substrate, but its biological function remains to be established (166) . This recent study demonstrated a specific interaction between 80K-H and TRPV5, colocalization of both proteins in the kidney, and similar transcriptional regulation by 1,25-(OH) 2 , and inactivation of its two EF-hand structures totally abolished Ca 2ϩ binding. Electrophysiological studies using 80K-H mutants showed that three domains of 80K-H (the two EF-hand structures, the highly acidic glutamic stretch, and the His-Asp-Glu-Leu sequence) are critical determinants for TRPV5 activity. Importantly, inactivation of the EF-hand pair reduced the TRPV5-mediated Ca 2ϩ current and increased the TRPV5 sensitivity to intracellular Ca 2ϩ , accelerating the feedback inhibition of the channel. None of the 80K-H mutants altered the TRPV5 plasma membrane localization nor the association of 80K-H with TRPV5, suggesting that 80K-H has a direct effect on TRPV5 activity (145) . Taken together, 80K-H acts as a novel Ca 2ϩ sensor controlling TRPV5 channel activity.
J. Diuretics
Diuretics such as furosemide and thiazides are frequently used in the clinical practice and are known to alter Ca 2ϩ metabolism. All of them are usually administered alone or in a combination of diuretics over a long period of time and are known to disturb Ca 2ϩ reabsorption leading to various symptoms including alterations in structure and stability of bone (422) . However, despite the widespread use of these diuretics, the molecular mechanism underlying their action on Ca 2ϩ reabsorption remains incompletely understood.
Furosemide
Loop diuretics, such as furosemide, inhibit the Na
Ϫ (NKCC2) transporter present in the apical membrane of the TALH resulting in a reduction in NaCl reabsorption and K ϩ recycling across the apical membrane. This action diminishes the lumen-positive potential, which is the driving force for paracellular Ca 2ϩ reabsorption in this particular nephron segment and explains the hypercalciuric effect of furosemide (123) . The calciuric effect of furosemide enhances the delivery of Ca 2ϩ to DCT and CNT, which are the primary sites of active Ca 2ϩ reabsorption. It is at present unknown whether these latter nephron segments partly compensate the hypercalciuric effect of the loop diuretics. In this respect, it is interesting to study the effect of furosemide on the expression and activity of the Ca 2ϩ transport proteins. This knowledge could also provide a rationale for TRPV5 or calbindin-D 28K activating treatment during furosemide application to reduce the side effect caused by the hypercalciuric action of furosemide. Until now, data about the molecular regulation of these proteins during furosemide treatment were not available.
Thiazides
Thiazides are the most widely prescribed drugs today, particularly by being the mainstay of first-line therapy in hypertension. In addition, these diuretics have, in contrast to loop diuretics, the unique characteristic of decreasing Na ϩ reabsorption while increasing Ca 2ϩ reabsorption (79). Their hypocalciuric effect provides therapeutic opportunities in, for instance, idiopathic hypercalciuria and nephrolithiasis. Furthermore, thiazides have been shown to increase bone mineral density and decrease fracture risk, spiking interest in the favorable longterm effects of these diuretics in counteracting osteoporosis (321). However, the exact molecular mechanism responsible for this thiazide-induced hypocalciuria has been a subject of discussion.
Thiazides increase renal Na ϩ excretion by inhibiting the Na ϩ -Cl Ϫ cotransporter (NCC) present in the apical membrane of DCT cells (255) . This inhibition of Na ϩ reabsorption results in increased renal salt and water loss and thereby decreases extracellular volume (255) . Costanzo and Windhager (79) showed in pioneering micropuncture and microperfusion experiments that chlorothiazide can stimulate Ca 2ϩ transport in DCT in situ. Their data are restricted to the acute effects of these diuretics on electrolyte transport and are difficult to translate to chronic thiazide treatment. Several theories, emphasizing an activation of transcellular Ca 2ϩ transport processes in DCT, were subsequently advanced to explain the hypocalciuria during thiazide administration. Stimulation of apical Ca 2ϩ entry has been suggested, mediated by hyperpolarization of the plasma membrane secondary to NCC inhibition (138) . Alternatively, enhanced basolateral Na ϩ / Ca 2ϩ exchange by upregulation of NCX1 secondary to decreased intracellular Na ϩ concentration has also been suggested as the principal responsible mechanism (101, 121, 123). However, the significant downregulation of NCX1 transcripts during thiazide treatment shown in this latter study is hard to reconcile with the proposed stimulation of Na ϩ /Ca 2ϩ exchange activity. Furthermore, calbindin-D 28K mRNA and protein abundance were also decreased during thiazide treatment (278) . Calbindin-D 28K facilitates diffusion of Ca 2ϩ through the cytosol and simultaneously serves as an intracellular Ca 2ϩ buffer to protect the cell from toxic Ca 2ϩ levels (107) . This substantial decrease of the Ca 2ϩ diffusion and buffering capacity would be detrimental in the presence of increased apical Ca 2ϩ entry and increased transcellular Ca 2ϩ transport. The above-described hypotheses rely on substantial colocalization in DCT of NCC and the proteins involved in active Ca 2ϩ transport. Extensive immunohistochemical studies demonstrated only minor overlap, whereas the Ca 2ϩ transporters (i.e., TRPV5, calbindin-D 28K , NCX1, and PMCA1b) completely colocalized (171, 240, 278). Interestingly, Loffing et al. (239) demonstrated that the DCT epithelium had lost the structural characteristics of electrolyte transporting epithelia after chronic thiazide treatment and the cells were in different stages of apoptosis. In apoptotic cells, calbindin-D 28K and PMCA1b were strongly decreased, and the NCC protein was shifted from the luminal membrane to the basal membrane and was found additionally in small membrane vesicles in intercellular and peritubular spaces. The consistently decreased expression of the Ca 2ϩ transporters during thiazide treatment strongly argues against stimulation of active Ca 2ϩ transport processes in chronic thiazide treatment. Furthermore, transcripts of NCC were drastically reduced in homogenates of kidney cortex and almost absent in damaged DCT cells (278) . All other tubular segments were unaffected by the treatment.
On the other hand, extracellular volume contraction leading to increased proximal Na ϩ reabsorption and thereby increasing the electrochemical gradient driving passive Ca 2ϩ transport in proximal tubule segments has been suggested as a possible additional effect, further decreasing overall Ca 2ϩ excretion. In addition to inhibition of NCC by thiazides, mutations in the gene encoding NCC have been shown to cause Gitelman's syndrome (354) . These patients suffer from hypovolemia, hypokalemic alkalosis, hypomagnesemia, and hypocalciuria (254) . The mechanism causing the hypocalciuria in Gitelman's syndrome has not been elucidated, but in general, similar hypotheses have been postulated as for the thiazide action (101). Early studies by Weinman and Eknoyan (424) already demonstrated that the escape from the chronic effects of chlorothiazide is due to a decrease in the glomerular filtration rate and to an increase in fractional reabsorption in the proximal tubule. Nijenhuis et al. (278) showed that the HCTZ-induced hypocalciuria was accompanied by a significant decrease in body weight compared with controls, illustrating that extracellular volume contraction occurred. Since Na ϩ depletion resulted in a similar hypocalciuria, it is likely that the extracellular fluid volume (ECV) contraction by itself is responsible for the thiazide-induced hypocalciuria. This is further supported by the finding that Na ϩ repletion during HCTZ treatment, thereby preventing the ECV contraction, normalized the calciuresis. In literature, volume contraction has merely been suggested as a contributing factor in thiazide-induced hypocalciuria (121, 123) . The underlying mechanism is an enhancement of proximal Na ϩ reabsorption observed in volume contraction by diuretics and Na ϩ restriction (110, 319, 416) , which leads to an increase in the electrochemical driving force for passive Ca 2ϩ reabsorption (57) . Indeed, thiazides are known to decrease lithium clearance, which is generally accepted as an inverse estimation of proximal Na ϩ reabsorption (215). In conclusion, chronic thiazide treatment exerts two major effects. First, thiazides induce a hypovolemia that stimulates the proximal electrolyte reabsorption and explains the hypocalciuria. Second, thiazide exposure leads to structural degeneration of DCT resulting in downregulation of the particular ion transporters. These data inquire revision of the generally postulated hypotheses on hypocalciuria in chronic thiazide treatment and Gitelman's disease, indicating a critical role of ECV contraction and the resulting enhancement of passive Ca 2ϩ reabsorption.
K. Immunosuppressants
Immunosuppressants like the calcineurin inhibitors tacrolimus (FK506) and cyclosporin A, next to glucocor-ticoids, such as dexamethasone, are widely prescribed drugs in various disorders and for organ transplant recipients. Although their immunosuppressive actions are accomplished by distinct mechanisms, FK506 and dexamethasone are both known to induce significant side effects on mineral homeostasis. These drugs are associated with an increased bone turnover, a negative Ca 2ϩ balance, and hypercalciuria, perturbations that can ultimately result in osteoporosis (323, 332, 367) . Furthermore, hypomagnesemia is a well-known additional consequence of FK506 treatment (6, 251) . The kidney is essential to both Ca 2ϩ and Mg 2ϩ homeostasis by providing the main excretory route for these divalent ions. However, the exact mechanisms by which these immunosuppressants provoke renal divalent wasting are unknown. The hypercalciuria during treatment with these drugs has been attributed to increased bone resorption as well as decreased renal Ca 2ϩ reabsorption (242, 323, 324) . Until now, the cascade of cellular and molecular events leading to impaired renal Ca 2ϩ handling during FK506 and glucocorticoid treatment is largely unknown. In theory, downregulation of Ca 2ϩ transport proteins in the distal part of the nephron may be involved in the pathogenesis of hypercalciuria and hypermagnesuria during drug treatment. Previous reports showed reduced calbindin-D 28K levels during FK506 treatment, suggesting that FK506 could affect active Ca 2ϩ transport (2) . Recently, it was demonstrated that FK506 treatment significantly increased urinary Ca 2ϩ excretion, accompanied by a downregulation of the renal mRNA expression of TRPV5 and calbindin-D 28K , and a specific reduction of the protein abundance of these Ca 2ϩ transport proteins in DCT and CNT (277) . The fact that serum Ca 2ϩ concentrations and glomerular filtration rate did not differ from controls confirmed that impaired Ca 2ϩ reabsorption rather than an increased filtered load caused the hypercalciuria. In addition, the expression of the major intestinal Ca 2ϩ transport proteins was not increased by FK506 treatment, excluding that hypercalciuria is secondary to upregulation of active Ca 2ϩ absorption. These data strongly supported the hypothesis that FK506 induces a primary defect of renal active Ca 2ϩ reabsorption by specifically downregulating the proteins involved in active Ca 2ϩ transport. The molecular mechanism underlying the downregulation of the Ca 2ϩ transport proteins by FK506 remains elusive. In previous studies, plasma 1,25-(OH) 2 D 3 was either unaltered or moderately increased, while plasma PTH was not affected by similar doses of FK506, which excludes that the reduced Ca 2ϩ transport protein expression levels are secondary to decreased circulating levels of these calciotropic hormones (2, 241) . Interestingly, several groups demonstrated that the immunosuppressive action of FK506 depends on the inhibition of the Ca 2ϩ -dependent phosphatase calcineurin in T-lymfocyten (131, 238, 295 reabsorption by these drugs (2, 366) . In addition, FK506 binds to intracellular immunophilins called FK506-binding proteins (FKBPs), which have been implicated as ion channel regulators (157, 338, 352) . In particular, FKBP4 was shown to bind and regulate the Ca 2ϩ -permeable Drosophila TRPL channel, and this binding was disrupted by the addition of FK506 (150) . Site-directed mutagenesis showed that mutations of P702Q or P709Q in the highly conserved TRPL sequence "701LPPPFNVLP709" eliminated interaction of the TRPL with the FK506-binding protein of Drosophila (dFKBP59). Detailed sequence alignment of TRPV5/6 species indicated that this domain is not conserved in the TRPV subfamily. Furthermore, several intracellular Ca 2ϩ release channels were shown to be modulated by binding of FKBPs (250) . Therefore, it is tempting to speculate that FKBPs are potential associated proteins regulating epithelial Ca 2ϩ channel expression or activity. Ϫ/Ϫ mice up to the last surface loop of the late proximal tubule (LPT) (Fig. 13A) . In contrast, mean Ca 2ϩ delivery to puncturing sites within distal convolution (DC; DCT and CNT), was significantly enhanced in TRPV5 Ϫ/Ϫ mice. Because K ϩ secretion occurs along the distal nephron sites accessible to micropuncture (together with water reabsorption in CNT and CCD), the distal luminal potassium concentration was used as an indicator of the distal collection site (Fig. 13B) . Based on the shape of the relationship between distal luminal K ϩ concentration and fractional Ca 2ϩ delivery, it is evident that in contrast to TRPV5 ϩ/ϩ mice, fractional Ca 2ϩ delivery increases with a higher K ϩ concentration, indicating a defect in Ca 2ϩ reabsorption along the DCT and CNT which is consistent with the localization of TRPV5.
VII. CHARACTERIZATION OF EPITHELIAL CALCIUM CHANNEL KNOCKOUT MICE
A. TRPV5 Knockout Mice
Interestingly, polyuria and polydipsia were consistently observed in TRPV5 Ϫ/Ϫ mice compared with TRPV5 ϩ/Ϫ and TRPV5 ϩ/ϩ littermates. Polyuria facilitates the excretion of large quantities of Ca 2ϩ by reducing the potential risk of Ca 2ϩ precipitations. It is known that a high luminal Ca 2ϩ concentration activates the CaSR in the apical membrane of the IMCD. As a consequence, the arginine vasopressin-elicited water permeability is blunted by a PKC-mediated aquaporin-2 retrieval mechanism to reduce water reabsorption and prevent a further rise in urinary Ca 2ϩ concentration and possibly stone formation (335) . The hypercalciuria-induced polyuria has been observed in humans (253) and animal models (119, 317) . Furthermore, TRPV5
Ϫ/Ϫ mice produced urine that was significantly more acidic compared with TRPV5 ϩ/ϩ and TRPV5 ϩ/Ϫ littermates. Acidification of the urine is also known to prevent renal stone formation in hypercalciuria, since Ca 2ϩ precipitates will not be formed at pH 5-6 (24) .
In general, Ca 2ϩ hyperabsorption by the small intestine is favored as compensation for renal Ca 2ϩ wasting. Ca 2ϩ absorption was assessed in preliminary experiments by measuring serum 45 Ca 2ϩ at early time points after oral gavage. A significant increase in the rate of 45 Ca 2ϩ absorption was observed in TRPV5 Ϫ/Ϫ mice compared with wild- Ϫ/Ϫ mice (n ϭ 9), assessed by quantitative PCR analysis, is calculated as a ratio to the HPRT mRNA. E: mRNA expression of TRPV6 and calbindin-D 9K in duodenum of TRPV5 ϩ/ϩ and TRPV5 Ϫ/Ϫ mice, assessed by quantitative PCR analysis, is calculated as a ratio to the HPRT mRNA (n ϭ 9). [Modified from Hoenderop et al. (180).] type littermates, indicating a compensatory role of the small intestine (Fig. 13C ). TRPV6 and calbindin-D 9K expression levels were significantly upregulated in TRPV5 Ϫ/Ϫ mice consistent with this increased Ca 2ϩ absorption (Fig. 13E) (180) .
Surprisingly, inactivation of the TRPV5 gene was accompanied by a decrease in the renal calbindin-D 28K and NCX1 mRNA expression (Fig. 13D) ϩ/ϩ mice (Fig. 14) . Trabecular bone volume, tissue volume, and bone fraction were not different between the genotypes (180). This could not be explained by a difference in trabecular number. Alternatively, it is possible that the trabeculae are longer, i.e., protrude further into the bone marrow cavity and thereby compensate for reduced trabecular thickness. Analyses of the diaphysis showed that cortical bone volume, cortical volume fraction, and cortical bone thickness were reduced in TRPV5 Ϫ/Ϫ versus TRPV5 ϩ/ϩ mice. These initial data from TRPV5 Ϫ/Ϫ mice demonstrated that TRPV5 is the gatekeeper in active Ca 2ϩ reabsorption. Ablation of the TRPV5 gene seriously disturbs renal Ca 2ϩ handling, causing increased 1,25-(OH) 2 D 3 plasma levels, Ca 2ϩ hyperabsorption, and reduced bone formation. All of these deficiencies have been reported frequently in patients with idiopathic hypercalciuria, although the molecular basis for this disorder remains unknown.
B. TRPV6 Knockout Mice
Hediger and co-workers (34) addressed the functional role of TRPV6 in Ca 2ϩ absorption by inactivation of the mouse TRPV6 gene. These TRPV6 null (TRPV6 Ϫ/Ϫ ) mice were placed on a Ca 2ϩ -deficient diet and subsequently challenged in a 45 Ca 2ϩ absorption assay. TRPV6 Ϫ/Ϫ mice showed a consistent decrease in Ca 2ϩ absorption over time. From these initial data it was concluded that TRPV6 Ϫ/Ϫ mice show a significant Ca 2ϩ malabsorption, suggesting that TRPV6 is indeed the ratelimiting step in 1,25-OH 2 D 3 -dependent Ca 2ϩ absorption. However, future studies are needed to address the functions of TRPV6 in detail.
VIII. OUTLOOK
Ca
2ϩ play a fundamental role in many cellular processes, and its extracellular concentration is kept under strict control to allow proper physiological functions. The transepithelial Ca 2ϩ (re)absorption determines the influx and efflux of Ca 2ϩ to the extracellular Ca 2ϩ pool and is controlled by several hormones. This review has focused on the identification, function, and regulation of the Ca 2ϩ transport proteins. Over the last years significant advances were achieved in the Ca 2ϩ homeostasis field. The picture that emerges from the recent data pointed to a cellular model for transepithelial Ca 2ϩ transport in which distinct players execute an essential role. The identification of the new epithelial Ca 2ϩ channels, TRPV5 and influx. Unique physiological functions important for body Ca 2ϩ homeostasis have been attributed to these gatekeeper channels, and many key questions in the study of transepithelial Ca 2ϩ transport can now be addressed. What is the three-dimensional structure of these Ca 2ϩ channels? Valuable information can be deduced from a structural models of TRPV5/6 channels. Future work should develop computational approaches to construct and refine three-dimensional models of these gatekeeper channels by incorporating and integrating available and new experimental data. How do intracellular Ca 2ϩ control epithelial Ca 2ϩ channel activity to allow sufficient Ca 2ϩ uptake and subsequent transcellular Ca 2ϩ movement? How is this Ca 2ϩ movement organized in the absorbing epithelial cell, and which signaling pathways are involved? What is the underlying mechanism of the stimulatory effect of the calciotropic hormones? In this respect, it will be important to identify regulatory domains in the epithelial Ca 2ϩ channels, binding partners of TRPV5/6 that participate in the channel complex and the signaling pathways controlling channel activity. Furthermore, what is the function of TRPV5/6 in unexplored tissues as testis, brain, exocrine tissues, stomach, and bone? Tissue-specific knockout mice models will help us to address these key functions of the Ca 2ϩ -transporting proteins. We have seen that ablation of the TRPV5 gene seriously disturbs renal Ca 2ϩ handling resulting in compensatory intestinal hyperabsorption and bone abnormalities. These deficiencies in Ca 2ϩ handling have been reported frequently in patients with idiopathic hypercalciuria, although the molecular basis is unknown and genetic defects in TRPV5, and/or TRPV6 remain to be identified. It is clear that despite considerable advances, much remains to be learned, and the field of Ca 2ϩ homeostasis will remain active for many more years. 
